{
  "tier": 3,
  "name": "Tier 3: Complex Designs",
  "description": "Power analysis benchmark tasks - tier 3",
  "tasks": [
    {
      "id": "t3-real-powertost-samplentost-001",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2\" crossover, CV=0.2, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 20
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST help page",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.TOST(alpha=0.05, targetpower=0.8, logscale=TRUE, theta0=0.95, theta1=0.8, theta2=1.25, CV=0.2, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-002",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2\" crossover, CV=0.3, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 40
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST help page CV=0.3",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.TOST(alpha=0.05, targetpower=0.8, logscale=TRUE, theta0=0.95, theta1=0.8, theta2=1.25, CV=0.3, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-003",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2\" crossover, CV=0.4, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 66
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST help page CV=0.4",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.TOST(alpha=0.05, targetpower=0.8, logscale=TRUE, theta0=0.95, theta1=0.8, theta2=1.25, CV=0.4, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-004",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x3\" crossover, CV=0.3, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 30
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST help page 3-period",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.TOST(alpha=0.05, targetpower=0.8, logscale=TRUE, theta0=0.95, CV=0.3, design=\"2x2x3\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-005",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"parallel\" crossover, CV=0.3, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 76
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST parallel design",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.TOST(alpha=0.05, targetpower=0.8, logscale=TRUE, theta0=0.95, CV=0.3, design=\"parallel\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powertost-006",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with significance level=0.05, true ratio=0.95, lower BE limit=0.8, theta2=1.25, CV=0.3, n per group=24. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.5577
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST help page",
        "source_type": "help_page_example"
      },
      "reference_code": "power.TOST(alpha=0.05, logscale=TRUE, theta0=0.95, theta1=0.8, theta2=1.25, CV=0.3, n=24, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenrsabe-007",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x3x3\" crossover, CV=0.4, GMR=0.9, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "CVwT": 0.4,
        "CVwR": 0.4,
        "theta0": 0.9,
        "theta1": 0.8,
        "theta2": 1.25,
        "Sample size": 33,
        "Achieved power": 0.8084,
        "Target power": 0.8,
        "nlast": 33
      },
      "tolerance": {
        "CVwT": 0.02,
        "CVwR": 0.02,
        "theta0": 0.045,
        "theta1": 0.04,
        "theta2": 2,
        "Sample size": 2,
        "Achieved power": 0.0404,
        "Target power": 0.04,
        "nlast": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE help page",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.RSABE(alpha=0.05, targetpower=0.8, CV=0.4, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplennoninf-008",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2\" crossover, CV=0.3, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 48
      },
      "tolerance": {
        "sample_size": 3
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf help page",
        "source_type": "help_page_example"
      },
      "reference_code": "sampleN.noninf(alpha=0.025, targetpower=0.8, logscale=TRUE, theta0=0.95, margin=0.8, CV=0.3, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gsdesign-009",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with k=3, alpha=0.025, beta=0.1, sfu=\"OF\": What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1
      },
      "tolerance": {
        "n_fix": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign help page - O Brien-Fleming 3-look",
        "source_type": "help_page_example"
      },
      "reference_code": "gsDesign(k=3, test.type=1, alpha=0.025, beta=0.1, sfu=\"OF\")",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gsdesign-010",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with k=3, alpha=0.025, beta=0.1, sfu=\"Pocock\": What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1
      },
      "tolerance": {
        "n_fix": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign help page - Pocock 3-look",
        "source_type": "help_page_example"
      },
      "reference_code": "gsDesign(k=3, test.type=1, alpha=0.025, beta=0.1, sfu=\"Pocock\")",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gsdesign-011",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with k=4, alpha=0.025, beta=0.2, sfu=\"OF\", sfl=\"Pocock\": What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1
      },
      "tolerance": {
        "n_fix": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign help page - 2-sided 4-look",
        "source_type": "help_page_example"
      },
      "reference_code": "gsDesign(k=4, test.type=2, alpha=0.025, beta=0.2, sfu=\"OF\", sfl=\"Pocock\")",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nsurv-012",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a power analysis with lambdaC=log(2, hr=0.75, eta=0.1, T=36, minfup=12, alpha=0.025: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 1592
      },
      "tolerance": {
        "sample_size": 80
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurv",
        "origin": "gsDesign::nSurv help page - survival",
        "source_type": "help_page_example"
      },
      "reference_code": "nSurv(lambdaC=log(2)/12, hr=0.75, eta=0.1, T=36, minfup=12, alpha=0.025, beta=0.10, ratio=1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nsurv-013",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a power analysis with lambdaC=log(2, hr=0.6, eta=0, T=24, minfup=12, alpha=0.025: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 152
      },
      "tolerance": {
        "sample_size": 8
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurv",
        "origin": "gsDesign::nSurv help page - aggressive HR",
        "source_type": "help_page_example"
      },
      "reference_code": "nSurv(lambdaC=log(2)/6, hr=0.6, eta=0, T=24, minfup=12, alpha=0.025, beta=0.20)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nbinomial-014",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p1=0.15, p2=0.1, alpha=0.025, beta=0.2, outtype=1: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 1371.2
      },
      "tolerance": {
        "value": 69
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial help page",
        "source_type": "help_page_example"
      },
      "reference_code": "nBinomial(p1=0.15, p2=0.10, alpha=0.025, beta=0.20, outtype=1)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mdescra2-015",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "A researcher plans a multilevel/cluster randomized trial with power=0.8, significance level=0.05, tailed=TRUE, rho2=0.1, J=20. What is the minimum detectable effect size (MDES)?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "mdes": 0.5046
      },
      "tolerance": {
        "mdes": 0.0101
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.cra2",
        "origin": "PowerUpR::mdes.cra2 help page",
        "source_type": "help_page_example"
      },
      "reference_code": "PowerUpR::mdes.cra2(power=0.80, alpha=0.05, two.tailed=TRUE, rho2=0.10, n=20, J=20)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mdesbira2-016",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "A researcher plans a multilevel/cluster randomized trial with power=0.8, significance level=0.05, tailed=TRUE, rho2=0.1, omega2=0.1, J=20. What is the minimum detectable effect size (MDES)?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "mdes": 0.2879
      },
      "tolerance": {
        "mdes": 0.0058
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.bira2",
        "origin": "PowerUpR::mdes.bira2 help page",
        "source_type": "help_page_example"
      },
      "reference_code": "PowerUpR::mdes.bira2(power=0.80, alpha=0.05, two.tailed=TRUE, rho2=0.10, omega2=0.10, n=20, J=20)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mdescra3-017",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "A researcher plans a multilevel/cluster randomized trial with power=0.8, significance level=0.05, tailed=TRUE, rho2=0.1, rho3=0.1, J=4, K=20. What is the minimum detectable effect size (MDES)?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "mdes": 0.5046
      },
      "tolerance": {
        "mdes": 0.0101
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.cra3",
        "origin": "PowerUpR::mdes.cra3 help page",
        "source_type": "help_page_example"
      },
      "reference_code": "PowerUpR::mdes.cra3(power=0.80, alpha=0.05, two.tailed=TRUE, rho2=0.10, rho3=0.10, n=10, J=4, K=20)",
      "tier": 3
    },
    {
      "id": "t3-real-trialsize-twosamplemeaneq-018",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "A researcher plans a equivalence trial with significance level=0.05, beta=0.2, sigma=0.1, k groups=1, difference=0.05, margin=0.2. What is the required sample size?",
      "expected_template": "equivalence",
      "ground_truth": {
        "sample_size": 7.6123
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "TrialSize",
        "function": "TwoSampleMean.Equivalence",
        "origin": "Chow/Shao/Wang - Two-sample mean equivalence",
        "source_type": "textbook_exercise"
      },
      "reference_code": "TrialSize::TwoSampleMean.Equivalence(alpha=0.05, beta=0.20, sigma=0.10, k=1, delta=0.05, margin=0.20)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nevents-021",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with hr=0.7, alpha=0.025, beta=0.1, r=1, tbl=TRUE: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n": 331
      },
      "tolerance": {
        "n": 17
      },
      "source": {
        "package": "gsDesign",
        "function": "nEvents",
        "origin": "keaven/gsDesign - gsDesign package survival vignette",
        "source_type": "github_repo",
        "url": "https://github.com/keaven/gsDesign/blob/master/vignettes/SurvivalOverview.Rmd"
      },
      "reference_code": "nEvents(hr = 0.7, alpha = 0.025, beta = 0.1, r = 1, tbl = TRUE)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nsurv-022",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Fixed survival design: sample size under Lachin-Foulkes method. What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 422
      },
      "tolerance": {
        "sample_size": 22
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurv",
        "origin": "keaven/gsDesign - gsDesign package survival vignette",
        "source_type": "github_repo",
        "url": "https://github.com/keaven/gsDesign/blob/master/vignettes/SurvivalOverview.Rmd"
      },
      "reference_code": "nSurv(lambdaC = log(2)/8, hr = 0.7, eta = 0.001, T = 28, minfup = 16, ratio = 1, alpha = 0.025, beta = 0.1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gssurv-023",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a power analysis with k=2, lambdaC=log(2, hr=0.7, eta=0.001, T=28, minfup=16: What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 329.1
      },
      "tolerance": {
        "n_fix": 17
      },
      "source": {
        "package": "gsDesign",
        "function": "gsSurv",
        "origin": "keaven/gsDesign - gsDesign package survival vignette",
        "source_type": "github_repo",
        "url": "https://github.com/keaven/gsDesign/blob/master/vignettes/SurvivalOverview.Rmd"
      },
      "reference_code": "gsSurv(k = 2, lambdaC = log(2)/8, hr = 0.7, eta = 0.001, T = 28, minfup = 16, ratio = 1, alpha = 0.025, beta = 0.1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-hrn2z-024",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Convert observed hazard ratio to Z-value (125 events, HR=0.73). What is the result?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "z_value": -1.7593
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "hrn2z",
        "origin": "keaven/gsDesign - gsDesign package survival vignette",
        "source_type": "github_repo",
        "url": "https://github.com/keaven/gsDesign/blob/master/vignettes/SurvivalOverview.Rmd"
      },
      "reference_code": "hrn2z(hr = 0.73, n = 125, ratio = 1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-zn2hr-025",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with z=1.96, n=120, ratio=1: What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "hazard_ratio": 0.6992
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "zn2hr",
        "origin": "keaven/gsDesign - gsDesign package survival vignette",
        "source_type": "github_repo",
        "url": "https://github.com/keaven/gsDesign/blob/master/vignettes/SurvivalOverview.Rmd"
      },
      "reference_code": "zn2hr(z = 1.96, n = 120, ratio = 1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gssurv-026",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Three-look O'Brien-Fleming group sequential survival design (n=906, 689 events). What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 674.0
      },
      "tolerance": {
        "n_fix": 34
      },
      "source": {
        "package": "gsDesign",
        "function": "gsSurv",
        "origin": "larry-leon/interim-analyses - Clinical trial interim analysis example using gsDesign",
        "source_type": "github_repo",
        "url": "https://github.com/larry-leon/interim-analyses/blob/main/Example1_gsDesign_example.Rnw"
      },
      "reference_code": "gsSurv(k=3, test.type=1, timing=c(0.50, 0.78, 1), R=c(1), gamma=c(906/26), eta=0.05/12, minfup=32, T=58, lambdaC=log(2)/16, hr=0.78, hr0=1, beta=0.12, alpha=0.02, sfu=\"OF\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-027",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for standard 2x2 crossover bioequivalence with CV=0.20. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 20
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.TOST(CV = 0.20)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-028",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for 4-period replicate design with widened acceptance limits. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 30
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.TOST(CV = 0.40, theta0 = 0.90, theta1 = 0.75, design = \"2x2x4\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-029",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for narrow therapeutic index drug with tight limits (90-111%). What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 32
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.TOST(CV = 0.125, theta0 = 0.975, theta1 = 0.90)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-030",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x3\" crossover, CV=0.45, GMR=0.9, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 124
      },
      "tolerance": {
        "sample_size": 7
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.TOST(CV = 0.45, theta0 = 0.90, design = \"2x2x3\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabel-031",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for scaled average bioequivalence with expanded limits. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 39
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.scABEL(CV = 0.45)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabel-032",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for ABEL under Gulf Cooperation Council widened limits. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 54
      },
      "tolerance": {
        "sample_size": 3
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.scABEL(CV = 0.45, regulator = \"GCC\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenrsabe-033",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for reference-scaled ABE with heteroscedastic variances. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 20
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.RSABE(CV = c(0.40, 0.50), design = \"2x2x4\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenratiof-034",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Sample size for ratio of means using Fieller's confidence interval. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 28
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RatioF",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.RatioF(CV = 0.20, CVb = 0.40)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplendp-035",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.2, target power=0.9): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 18
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.dp",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "sampleN.dp(CV = 0.20, doses = c(1, 2, 8), beta0 = 1, targetpower = 0.90)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powertost-036",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with CV=0.35, n per group=c(52. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.8011
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "Detlew/PowerTOST - PowerTOST package README examples for bioequivalence studies",
        "source_type": "github_repo",
        "url": "https://github.com/Detlew/PowerTOST/blob/master/README.Rmd"
      },
      "reference_code": "power.TOST(CV = 0.35, n = c(52, 49), design = \"parallel\")",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-powertstudent-037",
      "template": "power_analysis",
      "difficulty": "advanced",
      "question": "A researcher conducts a power analysis with effect size d=0.2, margin=-0.05, significance level=0.05. What is the required sample size?",
      "expected_template": "power_analysis",
      "ground_truth": {
        "sample_size": 199
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "pwrss",
        "function": "power.t.student",
        "origin": "metinbulus/pwrss - pwrss package README - Statistical Power and Sample Size Calculation Tools",
        "source_type": "github_repo",
        "url": "https://github.com/metinbulus/pwrss"
      },
      "reference_code": "power.t.student(d = 0.20, margin = -0.05, power = 0.80, alpha = 0.05, alternative = \"one.sided\", design = \"independent\")",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-powertstudent-038",
      "template": "power_analysis",
      "difficulty": "advanced",
      "question": "A researcher conducts a power analysis with effect size d=0, margin=c(-0.10, significance level=0.05. What is the required sample size?",
      "expected_template": "power_analysis",
      "ground_truth": {
        "sample_size": 1714
      },
      "tolerance": {
        "sample_size": 35
      },
      "source": {
        "package": "pwrss",
        "function": "power.t.student",
        "origin": "metinbulus/pwrss - pwrss package README - Statistical Power and Sample Size Calculation Tools",
        "source_type": "github_repo",
        "url": "https://github.com/metinbulus/pwrss"
      },
      "reference_code": "power.t.student(d = 0, margin = c(-0.10, 0.10), power = 0.80, alpha = 0.05, alternative = \"two.one.sided\", design = \"independent\")",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizeme-039",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Fixed design sample size for comparing two means (d=0.5, 80% power). What is the required total sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_total": 127.5
      },
      "tolerance": {
        "n_total": 7
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeMeans",
        "origin": "rpact-com/rpact - rpact step-by-step tutorial for clinical trial design",
        "source_type": "github_repo",
        "url": "https://www.rpact.org/vignettes/getting-started/rpact_step-by-step_tutorial/"
      },
      "reference_code": "getSampleSizeMeans(alpha = 0.05, sided = 2, alternative = 0.5)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getdesigngroups-040",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "3-look O'Brien-Fleming group sequential design with 90% power. What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "max_n": 141.8,
        "expected_n_H1": 107.1
      },
      "tolerance": {
        "max_n": 8,
        "expected_n_H1": 6
      },
      "source": {
        "package": "rpact",
        "function": "getDesignGroupSequential + getSampleSizeMeans",
        "origin": "rpact-com/rpact - rpact step-by-step tutorial for clinical trial design",
        "source_type": "github_repo",
        "url": "https://www.rpact.org/vignettes/getting-started/rpact_step-by-step_tutorial/"
      },
      "reference_code": "getDesignGroupSequential(kMax = 3, typeOfDesign = \"OF\", sided = 1, alpha = 0.05, beta = 0.1) |> getSampleSizeMeans(groups = 2, alternative = 0.5, stDev = 1, allocationRatioPlanned = 1, normalApproximation = FALSE)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getdesigngroups-041",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with typeOfDesign=\"asOF\", alpha=0.05, beta=0.1, typeBetaSpending=\"bsOF\": What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "max_n": 148.2,
        "expected_n_H1": 111.0
      },
      "tolerance": {
        "max_n": 8,
        "expected_n_H1": 6
      },
      "source": {
        "package": "rpact",
        "function": "getDesignGroupSequential + getSampleSizeMeans",
        "origin": "rpact-com/rpact - rpact step-by-step tutorial for clinical trial design",
        "source_type": "github_repo",
        "url": "https://www.rpact.org/vignettes/getting-started/rpact_step-by-step_tutorial/"
      },
      "reference_code": "getDesignGroupSequential(typeOfDesign = \"asOF\", alpha = 0.05, beta = 0.1, typeBetaSpending = \"bsOF\") |> getSampleSizeMeans(alternative = 0.5)",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrsst2means-042",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "Sample size for equivalence trial: margin \u00b10.10, true difference 0.05, sd=0.75. What is the required sample size per group?",
      "expected_template": "equivalence",
      "ground_truth": {
        "total_n": 7710,
        "n_per_group": 3855
      },
      "tolerance": {
        "total_n": 155,
        "n_per_group": 78
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.t.2means",
        "origin": "Penn State STAT 509. Clinical Trials SAS Examples.",
        "source_type": "software_doc",
        "url": "https://online.stat.psu.edu/stat509/lesson/6b/6b.8"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrsst2means-043",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "Sample size for equivalence trial with 2:1 allocation and 95% power. What is the required total sample size?",
      "expected_template": "equivalence",
      "ground_truth": {
        "total_n": 10959
      },
      "tolerance": {
        "total_n": 220
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.t.2means",
        "origin": "Penn State STAT 509. Clinical Trials SAS Examples.",
        "source_type": "software_doc",
        "url": "https://online.stat.psu.edu/stat509/lesson/6b/6b.8"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-044",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Sample size for non-inferiority trial comparing proportions 0.65 vs 0.70. What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "total_n": 3764,
        "n_per_group": 1882
      },
      "tolerance": {
        "total_n": 76,
        "n_per_group": 38
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Penn State STAT 509. Clinical Trials SAS Examples.",
        "source_type": "software_doc",
        "url": "https://online.stat.psu.edu/stat509/lesson/6b/6b.8"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-powersurve-ssizectdefault-045",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Sample size for non-inferiority survival trial with event rate 0.20. What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "total_n": 2914,
        "n_per_group": 1457
      },
      "tolerance": {
        "total_n": 146,
        "n_per_group": 73
      },
      "source": {
        "package": "powerSurvEpi",
        "function": "ssizeCT.default",
        "origin": "Penn State STAT 509. Clinical Trials SAS Examples.",
        "source_type": "software_doc",
        "url": "https://online.stat.psu.edu/stat509/lesson/6b/6b.8"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwr-pwrttest-046",
      "template": "ttest",
      "difficulty": "advanced",
      "question": "Sample size for superiority trial: difference=8, SD=40, 90% power (Julious 2004 2.1.1). What is the required sample size per group?",
      "expected_template": "ttest",
      "ground_truth": {
        "n_per_group": 526
      },
      "tolerance": {
        "n_per_group": 11
      },
      "source": {
        "package": "pwr",
        "function": "pwr.t.test",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Julious SA 2004.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwr-pwrttest-047",
      "template": "ttest",
      "difficulty": "advanced",
      "question": "Sample size for superiority trial: difference=0.5, SD=1.8, 95% power (Pocock 1983). What is the required sample size per group?",
      "expected_template": "ttest",
      "ground_truth": {
        "n_per_group": 337
      },
      "tolerance": {
        "n_per_group": 7
      },
      "source": {
        "package": "pwr",
        "function": "pwr.t.test",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Pocock 1983.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrsst2means-048",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "Sample size for equivalence trial: margin=10, SD=50, 90% power (Julious 2004 3.4.3). What is the required sample size per group?",
      "expected_template": "equivalence",
      "ground_truth": {
        "n_per_group": 650
      },
      "tolerance": {
        "n_per_group": 13
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.t.2means",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Julious 2004 3.4.3.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrsst2means-049",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Sample size for non-inferiority trial: margin=10, SD=40, 90% power (Julious 2004 4.1.1). What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "n_per_group": 337
      },
      "tolerance": {
        "n_per_group": 7
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.t.2means",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Julious 2004 4.1.1.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwr-pwr2ptest-050",
      "template": "two_proportions",
      "difficulty": "advanced",
      "question": "Sample size for binary superiority trial: p1=0.90 vs p2=0.95, 90% power (Pocock 1983). What is the required sample size per group?",
      "expected_template": "two_proportions",
      "ground_truth": {
        "n_per_group": 579
      },
      "tolerance": {
        "n_per_group": 12
      },
      "source": {
        "package": "pwr",
        "function": "pwr.2p.test",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Pocock 1983.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-051",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "Sample size for binary equivalence trial: p=0.70, margin=10% (Julious 2009). What is the required sample size per group?",
      "expected_template": "equivalence",
      "ground_truth": {
        "n_per_group": 546
      },
      "tolerance": {
        "n_per_group": 11
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Julious 2009 12.1.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-052",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "Sample size for binary equivalence trial: p=0.70, margin=20% (Julious 2009). What is the required sample size per group?",
      "expected_template": "equivalence",
      "ground_truth": {
        "n_per_group": 137
      },
      "tolerance": {
        "n_per_group": 3
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Julious 2009 12.1.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-053",
      "template": "equivalence",
      "difficulty": "advanced",
      "question": "Sample size for binary equivalence trial: p=0.90, margin=5% (Julious 2009). What is the required sample size per group?",
      "expected_template": "equivalence",
      "ground_truth": {
        "n_per_group": 936
      },
      "tolerance": {
        "n_per_group": 19
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Julious 2009 12.1.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-054",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Sample size for binary non-inferiority trial: p=0.80, margin=10% (Donner). What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "n_per_group": 145
      },
      "tolerance": {
        "n_per_group": 3
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Donner Example 3.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-055",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Sample size for binary non-inferiority trial: p=0.90, margin=20% (Blackwelder). What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "n_per_group": 39
      },
      "tolerance": {
        "n_per_group": 1
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Blackwelder Table 3.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-056",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Sample size for binary non-inferiority trial: p=0.85, margin=15% (Pocock 2003). What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "n_per_group": 120
      },
      "tolerance": {
        "n_per_group": 3
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Pocock 2003.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-057",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Non-inferiority trial for rheumatoid arthritis dose reduction: margin=20%. What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "total_n": 156,
        "n_per_group": 78
      },
      "tolerance": {
        "total_n": 4,
        "n_per_group": 2
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1(1):51-54. (Referencing RA non-inferiority trial)",
        "source_type": "textbook",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6955025/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-058",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Non-inferiority trial with unequal proportions (ps=0.60, pe=0.50), margin=20%. What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "n_per_group": 420
      },
      "tolerance": {
        "n_per_group": 9
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Blackwelder Table 3.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrssz2props-059",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Binary non-inferiority: p=0.70, margin=10%, 80% power (Pocock 1983). What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "n_per_group": 330
      },
      "tolerance": {
        "n_per_group": 7
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.z.2props",
        "origin": "Sealed Envelope. Power Calculator Validation. Referencing Pocock 1983.",
        "source_type": "software_doc",
        "url": "https://www.sealedenvelope.com/power/validation/"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-pwrss-pwrsst2means-060",
      "template": "non_inferiority",
      "difficulty": "advanced",
      "question": "Non-inferiority trial for LDL cholesterol: margin=0.05, sd=0.10, 80% power. What is the required sample size per group?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "total_n": 100,
        "n_per_group": 50
      },
      "tolerance": {
        "total_n": 2,
        "n_per_group": 1
      },
      "source": {
        "package": "pwrss",
        "function": "pwrss.t.2means",
        "origin": "Novustat. Continuous Outcome Non-Inferiority Trial example.",
        "source_type": "textbook",
        "url": "https://novustat.com/en/statistics-glossary/continuous-outcome-non-inferiority-trial.html"
      },
      "reference_code": "",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nnormal-061",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Two-sample normal: power with unequal variances and 2:1 randomization. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "power": 0.9467
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/nNormal.html"
      },
      "reference_code": "nNormal(delta1 = 0.8, sd = 1.6, sd2 = 1.25, alpha = 0.025, n = 200, ratio = 2)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nevents-062",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with n=100, alpha=0.025, hr=0.7, r=1: What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "power": 0.4299
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "nEvents",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/SurvivalOverview.html"
      },
      "reference_code": "nEvents(n = 100, alpha = 0.025, hr = 0.7, r = 1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-zn2hr-063",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with z=qnorm(0.975, n=120, ratio=1: What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "hazard_ratio": 0.6992
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "zn2hr",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/SurvivalOverview.html"
      },
      "reference_code": "zn2hr(z = qnorm(0.975), n = 120, ratio = 1)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-hrz2n-064",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with hr=0.8, z=qnorm(0.025, ratio=2: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 347.2
      },
      "tolerance": {
        "value": 18
      },
      "source": {
        "package": "gsDesign",
        "function": "hrz2n",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/SurvivalOverview.html"
      },
      "reference_code": "hrz2n(hr = 0.8, z = qnorm(0.025), ratio = 2)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gsdesign-065",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Basic group sequential design with 3 analyses and fixed n=200. What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 200
      },
      "tolerance": {
        "n_fix": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/gsDesignPackageOverview.html"
      },
      "reference_code": "gsDesign(n.fix = 200)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nsurv-066",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Fixed survival design with piecewise enrollment and 90% power. What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 775
      },
      "tolerance": {
        "sample_size": 39
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurv",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/gsSurvBasicExamples.html"
      },
      "reference_code": "nSurv(R = c(1, 2, 3, 4), gamma = c(1, 1.5, 2.5, 4), eta = 0.001, minfup = 12, T = 36, lambdaC = log(2)/12, hr = 0.75, hr0 = 1, beta = 0.1, alpha = 0.025)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gssurv-067",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Group sequential survival design with 3 analyses, OBF efficacy and HSD futility spending. What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 433.1
      },
      "tolerance": {
        "n_fix": 22
      },
      "source": {
        "package": "gsDesign",
        "function": "gsSurv",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/gsSurvBasicExamples.html"
      },
      "reference_code": "gsSurv(k = 3, timing = c(0.25, 0.75), R = c(1, 2, 3, 4), gamma = c(1, 1.5, 2.5, 4), eta = 0.001, minfup = 12, T = 36, lambdaC = log(2)/12, hr = 0.75, hr0 = 1, beta = 0.15, alpha = 0.025, sfu = sfLDOF, sfl = sfHSD, sflpar = -7)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nbinomial-068",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p1=0.2, p2=0.1, ratio=2, alpha=0.025, beta=0.15: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 495.6
      },
      "tolerance": {
        "value": 25
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialTwoSample.html"
      },
      "reference_code": "nBinomial(p1 = 0.2, p2 = 0.1, ratio = 2, alpha = 0.025, beta = 0.15)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nbinomial-069",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p1=0.2, p2=0.1, ratio=0.5, alpha=0.025, beta=0.15, scale=\"Difference\": What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 524.2
      },
      "tolerance": {
        "value": 27
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialTwoSample.html"
      },
      "reference_code": "nBinomial(p1 = 0.2, p2 = 0.1, ratio = 0.5, alpha = 0.025, beta = 0.15, scale = \"Difference\")",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nbinomial-070",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p1=0.2, p2=0.1, ratio=0.5, alpha=0.025, beta=0.15, scale=\"OR\": What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 488.8
      },
      "tolerance": {
        "value": 25
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialTwoSample.html"
      },
      "reference_code": "nBinomial(p1 = 0.2, p2 = 0.1, ratio = 0.5, alpha = 0.025, beta = 0.15, scale = \"OR\")",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nbinomial-071",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p1=0.2, p2=0.1, alpha=0.025, beta=0.15, ratio=0.5, delta0=-0.02: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 374.5
      },
      "tolerance": {
        "value": 19
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialTwoSample.html"
      },
      "reference_code": "nBinomial(p1 = 0.2, p2 = 0.1, alpha = 0.025, beta = 0.15, ratio = 0.5, delta0 = -0.02)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-nbinomial-072",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p1=0.2, p2=0.1, alpha=0.025, beta=0.15, ratio=0.5, delta0=0.02: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "sample_size": 795.9
      },
      "tolerance": {
        "value": 40
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialTwoSample.html"
      },
      "reference_code": "nBinomial(p1 = 0.2, p2 = 0.1, alpha = 0.025, beta = 0.15, ratio = 0.5, delta0 = 0.02)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-testbinomial-073",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with x1=20, n1=30, x2=10, n2=30: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "z_statistic": 2.582
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "testBinomial",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialTwoSample.html"
      },
      "reference_code": "testBinomial(x1 = 20, n1 = 30, x2 = 10, n2 = 30)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-binomialsprt-074",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Sequential probability ratio test for response rate monitoring. What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n1": 10,
        "n2": 11
      },
      "tolerance": {
        "n1": 2,
        "n2": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "binomialSPRT",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialSPRTExample.html"
      },
      "reference_code": "binomialSPRT(p0 = .1, p1 = .35, alpha = .08, beta = .2, minn = 10, maxn = 25)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-binomialsprt-075",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with p0=0.04, p1=0.1, alpha=0.04, beta=0.2, minn=4, maxn=75: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n1": 4,
        "n2": 5
      },
      "tolerance": {
        "n1": 2,
        "n2": 2
      },
      "source": {
        "package": "gsDesign",
        "function": "binomialSPRT",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/binomialSPRTExample.html"
      },
      "reference_code": "binomialSPRT(p0 = .04, p1 = .1, alpha = .04, beta = .2, minn = 4, maxn = 75)",
      "tier": 3
    },
    {
      "id": "t3-real-gsdesign-gssurv-076",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Vaccine efficacy trial: 3-look group sequential design with 3:1 randomization, VE=70%. What is the fixed-design sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 63.54
      },
      "tolerance": {
        "n_fix": 4
      },
      "source": {
        "package": "gsDesign",
        "function": "gsSurv",
        "origin": "CRAN gsDesign vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/gsDesign/vignettes/VaccineEfficacy.html"
      },
      "reference_code": "gsSurv(k = 3, test.type = 4, alpha = 0.025, beta = 0.1, timing = c(0.45, 0.7), sfu = sfHSD, sfupar = -3, sfl = sfHSD, sflpar = -3, lambdaC = 0.002, eta = 0.0001, hr = 0.3, hr0 = 0.7, R = 8, T = 24, minfup = 16, ratio = 3)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-077",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.3, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 40
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "sampleN.TOST(CV = 0.30)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powertost-078",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with CV=0.3, n per group=39. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.8056
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "power.TOST(CV = 0.30, n = 39)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-079",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "Average bioequivalence: sample size with CV=20% and theta0=0.92. What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 28
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "sampleN.TOST(CV = 0.20, theta0 = 0.92)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-expsamplentost-080",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x2\" crossover, CV=0.2, GMR=0.92, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 30
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "expsampleN.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "expsampleN.TOST(CV = 0.20, theta0 = 0.92, prior.type = \"CV\", prior.parm = list(m = 16, design = \"2x2x2\"))",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-expsamplentost-081",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x2\" crossover, CV=0.2, GMR=0.92, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 54
      },
      "tolerance": {
        "sample_size": 3
      },
      "source": {
        "package": "PowerTOST",
        "function": "expsampleN.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "expsampleN.TOST(CV = 0.20, theta0 = 0.92, prior.type = \"both\", prior.parm = list(m = 16, design = \"2x2x2\"))",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplentost-082",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x2\" crossover, CV=20, GMR=-5, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 52
      },
      "tolerance": {
        "sample_size": 3
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "sampleN.TOST(CV = 20, theta0 = -5, theta1 = -15, theta2 = 15, logscale = FALSE, design = \"2x2x2\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powertost-083",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with CV=0.25, true ratio=0.9, n per group=c(13. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.4963
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "power.TOST(CV = 0.25, theta0 = 0.90, n = c(13, 12))",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powertost-084",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with CV=0.22, true ratio=0.9, n per group=40. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.7687
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "power.TOST(CV = 0.22, theta0 = 0.90, n = 40)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-cvfromci-085",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with lower=0.8323, upper=1.0392, n per group=26. What is the estimated CV?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.3499
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "CVfromCI",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/ABE.html"
      },
      "reference_code": "CVfromCI(lower = 0.8323, upper = 1.0392, design = \"2x2x4\", n = 26)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplennoninf-086",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.25, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 36
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/NI.html"
      },
      "reference_code": "sampleN.noninf(CV = 0.25)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powernoninf-087",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with CV=0.25, n per group=35. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.8086
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.noninf",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/NI.html"
      },
      "reference_code": "power.noninf(CV = 0.25, n = 35)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplennoninf-088",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.25, GMR=1/0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 36
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/NI.html"
      },
      "reference_code": "sampleN.noninf(CV = 0.25, margin = 1.25, theta0 = 1/0.95)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplennoninf-089",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x4\" crossover, CV=0.35, GMR=0.95, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 32
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/NI.html"
      },
      "reference_code": "sampleN.noninf(design = \"2x2x4\", margin = 0.80, theta0 = 0.95, CV = 0.35)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-powernoninf-090",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "A researcher conducts a bioequivalence study with margin=1.25, CV=0.2, true ratio=1.05, n per group=32. What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "power": 0.9985
      },
      "tolerance": {
        "value": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.noninf",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/NI.html"
      },
      "reference_code": "power.noninf(design = \"2x2x4\", margin = 1.25, CV = 0.20, theta0 = 1.05, n = 32)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabel-091",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x4\" crossover, CV=0.35, GMR=0.9, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 34
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/NI.html"
      },
      "reference_code": "sampleN.scABEL(CV = 0.35, theta0 = 0.90, design = \"2x2x4\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabel-092",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 42
      },
      "tolerance": {
        "sample_size": 3
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.scABEL(CV = 0.55)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabel-093",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 39
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.scABEL(CV = 0.55, regulator = \"HC\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabel-094",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 75
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.scABEL(CV = 0.55, regulator = \"GCC\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenrsabe-095",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 30
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.RSABE(CV = 0.55)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenntid-096",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.125, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 16
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.NTID",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.NTID(CV = 0.125)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenhvntid-097",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.3, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 22
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.HVNTID",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.HVNTID(CV = 0.30)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplenscabelad-098",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x4\" crossover, CV=0.35, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 38
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL.ad",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/RSABE.html"
      },
      "reference_code": "sampleN.scABEL.ad(CV = 0.35, design = \"2x2x4\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplendp-099",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.2, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 15
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.dp",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/DP.html"
      },
      "reference_code": "sampleN.dp(CV = 0.20, doses = c(10, 20, 33.3), beta0 = 1.02)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplendp-100",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.2, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 16
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.dp",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/DP.html"
      },
      "reference_code": "sampleN.dp(CV = 0.20, doses = c(10, 20, 33.3, 50), beta0 = 1.02)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplendp-101",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"crossover\" crossover, CV=0.3, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 70
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.dp",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/DP.html"
      },
      "reference_code": "sampleN.dp(CV = 0.30, doses = c(1, 4, 16, 64, 256), beta0 = 1.02, design = \"crossover\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-samplendp-102",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"crossover\" crossover, CV=0.3, target power=0.8): What is the required sample size?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "sample_size": 30
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.dp",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/DP.html"
      },
      "reference_code": "sampleN.dp(CV = 0.30, doses = c(1, 4, 16, 64, 256), beta0 = 1.02, design = \"crossover\", theta1 = 0.75)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-paabe-103",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.2, GMR=0.92, target power=0.8): What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "n": 28,
        "power": 0.8227
      },
      "tolerance": {
        "n": 2,
        "power": 0.0411
      },
      "source": {
        "package": "PowerTOST",
        "function": "pa.ABE",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/PA.html"
      },
      "reference_code": "pa.ABE(CV = 0.20, theta0 = 0.92)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-pascabe-104",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "n": 42,
        "power": 0.8085
      },
      "tolerance": {
        "n": 3,
        "power": 0.0404
      },
      "source": {
        "package": "PowerTOST",
        "function": "pa.scABE",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/PA.html"
      },
      "reference_code": "pa.scABE(CV = 0.55)",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-pascabe-105",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (\"2x2x4\" crossover, CV=0.4, target power=0.8): What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "n": 30,
        "power": 0.8066
      },
      "tolerance": {
        "n": 2,
        "power": 0.0403
      },
      "source": {
        "package": "PowerTOST",
        "function": "pa.scABE",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/PA.html"
      },
      "reference_code": "pa.scABE(CV = 0.40, design = \"2x2x4\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-pascabe-106",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "n": 39,
        "power": 0.8142
      },
      "tolerance": {
        "n": 2,
        "power": 0.0407
      },
      "source": {
        "package": "PowerTOST",
        "function": "pa.scABE",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/PA.html"
      },
      "reference_code": "pa.scABE(CV = 0.55, regulator = \"HC\")",
      "tier": 3
    },
    {
      "id": "t3-real-powertost-pascabe-107",
      "template": "bioequivalence",
      "difficulty": "advanced",
      "question": "For a bioequivalence study (2x2 crossover, CV=0.55, target power=0.8): What is the statistical power?",
      "expected_template": "bioequivalence",
      "ground_truth": {
        "n": 75,
        "power": 0.8021
      },
      "tolerance": {
        "n": 4,
        "power": 0.0401
      },
      "source": {
        "package": "PowerTOST",
        "function": "pa.scABE",
        "origin": "CRAN PowerTOST vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerTOST/vignettes/PA.html"
      },
      "reference_code": "pa.scABE(CV = 0.55, regulator = \"GCC\")",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mdescra3-108",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "A researcher plans a multilevel/cluster randomized trial with power=0.8, rho2=0.06, rho3=0.18, g3=1, r21=0.55, r22=0.5, r23=0.45, proportion=0.4. What is the minimum detectable effect size (MDES)?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "mdes": 0.2301
      },
      "tolerance": {
        "mdes": 0.005
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.cra3",
        "origin": "CRAN PowerUpR vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerUpR/vignettes/three_level_cluster_randomized_trial.html"
      },
      "reference_code": "mdes.cra3(power=.80, rho2=.06, rho3=.18, g3=1, r21=.55, r22=.50, r23=.45, p=.40, n=10, J=2, K=83)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-powercra3-109",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "For a multilevel/cluster randomized trial with es=0.23, rho2=0.06, rho3=0.18, g3=1, r21=0.55, r22=0.5, r23=0.45, p=0.4, n=10, J=2, K=83: What is the statistical power?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "power": 0.7998
      },
      "tolerance": {
        "power": 0.04
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra3",
        "origin": "CRAN PowerUpR vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerUpR/vignettes/three_level_cluster_randomized_trial.html"
      },
      "reference_code": "power.cra3(es=.23, rho2=.06, rho3=.18, g3=1, r21=.55, r22=.50, r23=.45, p=.40, n=10, J=2, K=83)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mrsscra3-110",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "For a multilevel/cluster randomized trial with es=0.1, power=0.8, rho2=0.06, rho3=0.18, g3=1, r21=0.55, r22=0.5, r23=0.45, p=0.4, n=10, J=2: What is the required sample size?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "n": 3
      },
      "tolerance": {
        "n": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra3",
        "origin": "CRAN PowerUpR vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerUpR/vignettes/vectorization_over_arbitary_parameters.html"
      },
      "reference_code": "mrss.cra3(es = 0.10, power = .80, rho2 = .06, rho3 = .18, g3 = 1, r21 = .55, r22 = .50, r23 = .45, p = .40, n = 10, J = 2)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mrsscra3-111",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "For a multilevel/cluster randomized trial with es=0.25, power=0.8, rho2=0.06, rho3=0.18, g3=1, r21=0.55, r22=0.5, r23=0.45, p=0.4, n=10, J=2: What is the required sample size?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "n": 3
      },
      "tolerance": {
        "n": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra3",
        "origin": "CRAN PowerUpR vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerUpR/vignettes/vectorization_over_arbitary_parameters.html"
      },
      "reference_code": "mrss.cra3(es = 0.25, power = .80, rho2 = .06, rho3 = .18, g3 = 1, r21 = .55, r22 = .50, r23 = .45, p = .40, n = 10, J = 2)",
      "tier": 3
    },
    {
      "id": "t3-real-powerupr-mrsscra3-112",
      "template": "multilevel_rct",
      "difficulty": "advanced",
      "question": "For a multilevel/cluster randomized trial with es=0.5, power=0.8, rho2=0.06, rho3=0.18, g3=1, r21=0.55, r22=0.5, r23=0.45, p=0.4, n=10, J=2: What is the required sample size?",
      "expected_template": "multilevel_rct",
      "ground_truth": {
        "n": 3
      },
      "tolerance": {
        "n": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra3",
        "origin": "CRAN PowerUpR vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/PowerUpR/vignettes/vectorization_over_arbitary_parameters.html"
      },
      "reference_code": "mrss.cra3(es = 0.50, power = .80, rho2 = .06, rho3 = .18, g3 = 1, r21 = .55, r22 = .50, r23 = .45, p = .40, n = 10, J = 2)",
      "tier": 3
    },
    {
      "id": "t3-real-longpower-digglelinearpow-113",
      "template": "longitudinal",
      "difficulty": "advanced",
      "question": "Longitudinal linear model: sample size per group (Diggle method). What is the required sample size?",
      "expected_template": "longitudinal",
      "ground_truth": {
        "sample_size": 313
      },
      "tolerance": {
        "sample_size": 16
      },
      "source": {
        "package": "longpower",
        "function": "diggle.linear.power",
        "origin": "CRAN longpower vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/longpower/vignettes/longpower.html"
      },
      "reference_code": "diggle.linear.power(d=0.5, t=c(0,2,5), sigma2=100, R=0.2, alternative=\"one.sided\", power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-real-longpower-digglelinearpow-114",
      "template": "longitudinal",
      "difficulty": "advanced",
      "question": "For a longitudinal study power analysis with d=0.5, t=c(0, sigma2=100, R=0.5, power=0.8: What is the required sample size?",
      "expected_template": "longitudinal",
      "ground_truth": {
        "sample_size": 196
      },
      "tolerance": {
        "sample_size": 10
      },
      "source": {
        "package": "longpower",
        "function": "diggle.linear.power",
        "origin": "CRAN longpower vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/longpower/vignettes/longpower.html"
      },
      "reference_code": "diggle.linear.power(d=0.5, t=c(0,2,5), sigma2=100, R=0.5, alternative=\"one.sided\", power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-real-longpower-digglelinearpow-115",
      "template": "longitudinal",
      "difficulty": "advanced",
      "question": "For a longitudinal study power analysis with d=0.5, t=c(0, sigma2=100, R=0.8, power=0.8: What is the required sample size?",
      "expected_template": "longitudinal",
      "ground_truth": {
        "sample_size": 79
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "longpower",
        "function": "diggle.linear.power",
        "origin": "CRAN longpower vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/longpower/vignettes/longpower.html"
      },
      "reference_code": "diggle.linear.power(d=0.5, t=c(0,2,5), sigma2=100, R=0.8, alternative=\"one.sided\", power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-real-longpower-digglelinearpow-116",
      "template": "longitudinal",
      "difficulty": "advanced",
      "question": "For a longitudinal study power analysis with d=0.5, t=c(0, sigma2=200, R=0.2, power=0.8: What is the required sample size?",
      "expected_template": "longitudinal",
      "ground_truth": {
        "sample_size": 625
      },
      "tolerance": {
        "sample_size": 32
      },
      "source": {
        "package": "longpower",
        "function": "diggle.linear.power",
        "origin": "CRAN longpower vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/longpower/vignettes/longpower.html"
      },
      "reference_code": "diggle.linear.power(d=0.5, t=c(0,2,5), sigma2=200, R=0.2, alternative=\"one.sided\", power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-real-longpower-digglelinearpow-117",
      "template": "longitudinal",
      "difficulty": "advanced",
      "question": "Longitudinal linear model: sample size with sigma2=300, R=0.8. What is the required sample size?",
      "expected_template": "longitudinal",
      "ground_truth": {
        "sample_size": 235
      },
      "tolerance": {
        "sample_size": 12
      },
      "source": {
        "package": "longpower",
        "function": "diggle.linear.power",
        "origin": "CRAN longpower vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/longpower/vignettes/longpower.html"
      },
      "reference_code": "diggle.linear.power(d=0.5, t=c(0,2,5), sigma2=300, R=0.8, alternative=\"one.sided\", power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-real-longpower-liulianglinearp-118",
      "template": "longitudinal",
      "difficulty": "advanced",
      "question": "Alzheimer's trial: sample size for ADAS-Cog slope difference of 1.5 points. What is the required sample size?",
      "expected_template": "longitudinal",
      "ground_truth": {
        "N": 415,
        "n_per_arm": 207.3
      },
      "tolerance": {
        "N": 21,
        "n_per_arm": 11
      },
      "source": {
        "package": "longpower",
        "function": "liu.liang.linear.power",
        "origin": "CRAN longpower vignette",
        "source_type": "cran_vignette",
        "url": "https://cran.r-project.org/web/packages/longpower/vignettes/longpower.html"
      },
      "reference_code": "liu.liang.linear.power(d=1.5, u=list(u1=seq(0,1.5,0.25), u2=rep(0,7)), v=list(v1=cbind(1,1,seq(0,1.5,0.25)), v2=cbind(1,0,seq(0,1.5,0.25))), R=R, sig.level=0.05, power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizeme-119",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with stDev=24, sided=2, alpha=0.05, beta=0.2: What is the required sample size per group?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 183,
        "n_per_group": 91.4
      },
      "tolerance": {
        "N": 10,
        "n_per_group": 5
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeMeans",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_continuous_examples/index.html"
      },
      "reference_code": "getSampleSizeMeans(alternative = 10, stDev = 24, sided = 2, alpha = 0.05, beta = 0.2)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizeme-120",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with stDev=24, allocationRatioPlanned=2, sided=2, alpha=0.05, beta=0.2: What is the required total sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 206
      },
      "tolerance": {
        "N": 11
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeMeans",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_continuous_examples/index.html"
      },
      "reference_code": "getSampleSizeMeans(alternative = 10, stDev = 24, allocationRatioPlanned = 2, sided = 2, alpha = 0.05, beta = 0.2)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getpowermeans-121",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with stDev=24, sided=2, allocationRatioPlanned=2, maxNumberOfSubjects=206, alpha=0.05: What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "power": 0.9203
      },
      "tolerance": {
        "power": 0.046
      },
      "source": {
        "package": "rpact",
        "function": "getPowerMeans",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_continuous_examples/index.html"
      },
      "reference_code": "getPowerMeans(alternative = 12, stDev = 24, sided = 2, allocationRatioPlanned = 2, maxNumberOfSubjects = 206, alpha = 0.05)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizeme-122",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with thetaH0=-12, stDev=14, alpha=0.025, beta=0.2, sided=1: What is the required sample size per group?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 45,
        "n_per_group": 22.4
      },
      "tolerance": {
        "N": 3,
        "n_per_group": 2
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeMeans",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_continuous_examples/index.html"
      },
      "reference_code": "getSampleSizeMeans(thetaH0 = -12, alternative = 0, stDev = 14, alpha = 0.025, beta = 0.2, sided = 1)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizera-123",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a statistical test with pi2=0.25, pi1=0.4, sided=1, significance level=0.025, beta=0.2: what is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 304,
        "n_per_group": 151.9
      },
      "tolerance": {
        "N": 16,
        "n_per_group": 8
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeRates",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_binary_examples/index.html"
      },
      "reference_code": "getSampleSizeRates(pi2 = 0.25, pi1 = 0.4, sided = 1, alpha = 0.025, beta = 0.2)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizera-124",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with pi2=0.25, pi1=0.4, sided=1, alpha=0.025, beta=0.2, allocationRatioPlanned=2: What is the required total sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 347
      },
      "tolerance": {
        "N": 18
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeRates",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_binary_examples/index.html"
      },
      "reference_code": "getSampleSizeRates(pi2 = 0.25, pi1 = 0.4, sided = 1, alpha = 0.025, beta = 0.2, allocationRatioPlanned = 2)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getpowerrates-125",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with pi2=0.25, pi1=0.37, maxNumberOfSubjects=304, sided=1, alpha=0.025: What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "power": 0.6196
      },
      "tolerance": {
        "power": 0.031
      },
      "source": {
        "package": "rpact",
        "function": "getPowerRates",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_binary_examples/index.html"
      },
      "reference_code": "getPowerRates(pi2 = 0.25, pi1 = 0.37, maxNumberOfSubjects = 304, sided = 1, alpha = 0.025)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizera-126",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with pi2=0.2, pi1=0.2, thetaH0=0.1, sided=1, alpha=0.025, beta=0.2: What is the required total sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 509
      },
      "tolerance": {
        "N": 26
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeRates",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_binary_examples/index.html"
      },
      "reference_code": "getSampleSizeRates(pi2 = 0.2, pi1 = 0.2, thetaH0 = 0.1, sided = 1, alpha = 0.025, beta = 0.2)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizera-127",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a group sequential design with groups=1, thetaH0=0.1, pi1=0.25, normalApproximation=FALSE, sided=1, alpha=0.025, beta=0.2: What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n": 53
      },
      "tolerance": {
        "n": 3
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeRates",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_binary_examples/index.html"
      },
      "reference_code": "getSampleSizeRates(groups = 1, thetaH0 = 0.1, pi1 = 0.25, normalApproximation = FALSE, sided = 1, alpha = 0.025, beta = 0.2)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizesu-128",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a statistical test with sided=2, significance level=0.05, beta=0.2, hazardRatio=0.74, dropoutRate1=0.025, dropoutRate2=0.025, dropoutTime=12, maxNumberOfSubjects=1200: what is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "events": 346.3,
        "analysis_time": 53.11
      },
      "tolerance": {
        "events": 18,
        "analysis_time": 3
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeSurvival",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_survival_examples/index.html"
      },
      "reference_code": "getSampleSizeSurvival(sided = 2, alpha = 0.05, beta = 0.2, lambda2 = log(2)/60, hazardRatio = 0.74, dropoutRate1 = 0.025, dropoutRate2 = 0.025, dropoutTime = 12, accrualTime = c(0,1,2,3,4,5,6), accrualIntensity = c(6,12,18,24,30,36,42), maxNumberOfSubjects = 1200)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizesu-129",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "For a power analysis with sided=2, alpha=0.05, beta=0.2, lambda2=log(2, hazardRatio=0.74, dropoutRate1=0.025: What is the required total sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 1434,
        "events": 346.3,
        "analysis_time": 49.13
      },
      "tolerance": {
        "N": 72,
        "events": 18,
        "analysis_time": 3
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeSurvival",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_survival_examples/index.html"
      },
      "reference_code": "getSampleSizeSurvival(sided = 2, alpha = 0.05, beta = 0.2, lambda2 = log(2)/60, hazardRatio = 0.74, dropoutRate1 = 0.025, dropoutRate2 = 0.025, dropoutTime = 12, accrualTime = c(0,1,2,3,4,5,6), accrualIntensity = c(6,12,18,24,30,36,42), followUpTime = 12)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizesu-130",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Survival non-inferiority trial: sample size with HR margin=1.2. What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 2610,
        "events": 944.5,
        "study_duration": 77.12
      },
      "tolerance": {
        "N": 131,
        "events": 48,
        "study_duration": 4
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeSurvival",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_survival_examples/index.html"
      },
      "reference_code": "getSampleSizeSurvival(sided = 1, alpha = 0.025, beta = 0.2, lambda2 = log(2)/60, thetaH0 = 1.2, hazardRatio = 1, dropoutRate1 = 0.025, dropoutRate2 = 0.025, dropoutTime = 12, accrualTime = c(0,1,2,3,4,5,6), accrualIntensity = c(6,12,18,24,30,36,42), followUpTime = 12)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizesu-131",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Group sequential survival design with 3 analyses using OBF spending. What is the required total sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "max_events": 386.8,
        "N": 1000,
        "expected_study_duration": 43.87
      },
      "tolerance": {
        "max_events": 20,
        "N": 50,
        "expected_study_duration": 3
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeSurvival",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_survival_examples/index.html"
      },
      "reference_code": "design <- getDesignGroupSequential(sided = 1, alpha = 0.025, beta = 0.2, informationRates = c(0.5, 0.75, 1), typeOfDesign = \"asOF\")\ngetSampleSizeSurvival(design = design, piecewiseSurvivalTime = piecewiseSurvivalTime, hazardRatio = 0.75, dropoutRate1 = 0.05, dropoutRate2 = 0.05, dropoutTime = 12, accrualTime = 0, accrualIntensity = 42, maxNumberOfSubjects = 1000)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizeme-132",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Group sequential design: Pocock alpha-spending with 3 analyses, 90% power. What is the required sample size?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N_stage1": 65.4,
        "N_stage2": 130.9,
        "N_stage3": 196.3
      },
      "tolerance": {
        "N_stage1": 4,
        "N_stage2": 7,
        "N_stage3": 10
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeMeans",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/getting-started/rpact_step-by-step_tutorial/index.html"
      },
      "reference_code": "getDesignGroupSequential(kMax = 3, typeOfDesign = \"asP\", sided = 2, alpha = 0.05, beta = 0.1) |> getSampleSizeMeans(groups = 2, alternative = 0.5, stDev = 1)",
      "tier": 3
    },
    {
      "id": "t3-real-rpact-getsamplesizera-133",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "Group sequential binary endpoint: 3 analyses with non-binding futility. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "N": 267,
        "expected_N_under_H1": 198.3,
        "power": 0.9
      },
      "tolerance": {
        "N": 14,
        "expected_N_under_H1": 10,
        "power": 0.045
      },
      "source": {
        "package": "rpact",
        "function": "getSampleSizeRates",
        "origin": "CRAN rpact vignette",
        "source_type": "rpact_vignette",
        "url": "https://www.rpact.org/vignettes/planning/rpact_binary_planning_example/index.html"
      },
      "reference_code": "dGS <- getDesignGroupSequential(informationRates = c(0.5, 0.75, 1), alpha = 0.025, beta = 0.1, futilityBounds = c(0, 0.5))\ngetSampleSizeRates(dGS, pi1 = 0.4, pi2 = 0.6)",
      "tier": 3
    },
    {
      "id": "t3-mk-powermpeknownvar-041",
      "template": "multiple_endpoints",
      "difficulty": "advanced",
      "question": "A dermatologist has 198 participants for a group sequential design with interim analyses studying hypertension. What is the required sample size?",
      "expected_template": "multiple_endpoints",
      "ground_truth": {
        "sample_size": 198
      },
      "tolerance": {
        "sample_size": 4
      },
      "source": {
        "package": "MKpower",
        "function": "power.mpe.known.var",
        "origin": "MKpower::power.mpe.known.var CRAN documentation",
        "variation": "mpe_known_K3_rho03",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(MKpower)\npower.mpe.known.var(K=3, delta=c(0.25, 0.5, 0.75), SD=c(1,1,1), rho=c(0.3, 0.3, 0.3), power=0.80, sig.level=0.05)",
      "tier": 3
    },
    {
      "id": "t3-mk-powermpeknownvar-042",
      "template": "multiple_endpoints",
      "difficulty": "intermediate",
      "question": "A ophthalmologist has 64 participants for a group sequential design with interim analyses studying type 2 diabetes. What is the required sample size?",
      "expected_template": "multiple_endpoints",
      "ground_truth": {
        "sample_size": 64
      },
      "tolerance": {
        "sample_size": 2
      },
      "source": {
        "package": "MKpower",
        "function": "power.mpe.known.var",
        "origin": "MKpower::power.mpe.known.var CRAN documentation",
        "variation": "mpe_known_K2_rho05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(MKpower)\npower.mpe.known.var(K=2, delta=c(0.5, 0.5), SD=c(1,1), rho=0.5, power=0.80, sig.level=0.05)",
      "tier": 3
    },
    {
      "id": "t3-mk-powermpeatleastone-043",
      "template": "multiple_endpoints",
      "difficulty": "advanced",
      "question": "A nephrologist has 44 participants for a group sequential design with interim analyses studying major depressive disorder. What is the required sample size?",
      "expected_template": "multiple_endpoints",
      "ground_truth": {
        "sample_size": 44
      },
      "tolerance": {
        "sample_size": 1
      },
      "source": {
        "package": "MKpower",
        "function": "power.mpe.atleast.one",
        "origin": "MKpower::power.mpe.atleast.one CRAN documentation",
        "variation": "mpe_atleast1_K2_rho05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(MKpower)\npower.mpe.atleast.one(K=2, delta=c(0.5, 0.5), SD=c(1,1), rho=0.5, power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-mk-powermpeatleastone-044",
      "template": "multiple_endpoints",
      "difficulty": "advanced",
      "question": "A infectious disease specialist has 101 participants for a group sequential design with interim analyses studying chronic pain. What is the required sample size?",
      "expected_template": "multiple_endpoints",
      "ground_truth": {
        "sample_size": 101
      },
      "tolerance": {
        "sample_size": 3
      },
      "source": {
        "package": "MKpower",
        "function": "power.mpe.atleast.one",
        "origin": "MKpower::power.mpe.atleast.one CRAN documentation",
        "variation": "mpe_atleast1_K3_rho03",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(MKpower)\npower.mpe.atleast.one(K=3, delta=c(0.3, 0.3, 0.3), SD=c(1,1,1), rho=c(0.3, 0.3, 0.3), power=0.80)",
      "tier": 3
    },
    {
      "id": "t3-pupr-001",
      "template": "individual_rct",
      "difficulty": "basic",
      "question": "An hematologist is designing a individual-level randomized trial . The expected effect size is 0.25. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "n": 504
      },
      "tolerance": {
        "n": 26
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.ira",
        "origin": "PowerUpR::mrss.ira CRAN documentation",
        "variation": "ira_es25_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.ira(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE)",
      "tier": 3
    },
    {
      "id": "t3-pupr-002",
      "template": "individual_rct",
      "difficulty": "basic",
      "question": "An clinical nutritionist is designing a individual-level randomized trial . The expected effect size is 0.2. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "n": 787
      },
      "tolerance": {
        "n": 40
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.ira",
        "origin": "PowerUpR::mrss.ira CRAN documentation",
        "variation": "ira_es20_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.ira(es=0.20, power=0.80, alpha=0.05, two.tailed=TRUE)",
      "tier": 3
    },
    {
      "id": "t3-pupr-003",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An rehabilitation specialist is designing a individual-level randomized trial . The expected effect size is 0.25. At significance level of 0.05 with 90% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "n": 674
      },
      "tolerance": {
        "n": 34
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.ira",
        "origin": "PowerUpR::mrss.ira CRAN documentation",
        "variation": "ira_es25_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.ira(es=0.25, power=0.90, alpha=0.05, two.tailed=TRUE)",
      "tier": 3
    },
    {
      "id": "t3-pupr-004",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An occupational therapist is designing a individual-level randomized trial . The expected effect size is 0.25. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "n": 253
      },
      "tolerance": {
        "n": 13
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.ira",
        "origin": "PowerUpR::mrss.ira CRAN documentation",
        "variation": "ira_es25_r21_50",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.ira(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, r21=0.50)",
      "tier": 3
    },
    {
      "id": "t3-pupr-005",
      "template": "individual_rct",
      "difficulty": "basic",
      "question": "An speech pathologist is running a individual-level randomized trial . The expected effect size is 0.25. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "power": 0.4205
      },
      "tolerance": {
        "power": 0.0126
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.ira",
        "origin": "PowerUpR::power.ira CRAN documentation",
        "variation": "power_ira_n200",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.ira(es=0.25, alpha=0.05, two.tailed=TRUE, n=200)",
      "tier": 3
    },
    {
      "id": "t3-pupr-006",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An physical therapist is running a individual-level randomized trial . The expected effect size is 0.2. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "power": 0.6071
      },
      "tolerance": {
        "power": 0.0182
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.ira",
        "origin": "PowerUpR::power.ira CRAN documentation",
        "variation": "power_ira_n500_es20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.ira(es=0.20, alpha=0.05, two.tailed=TRUE, n=500)",
      "tier": 3
    },
    {
      "id": "t3-pupr-007",
      "template": "individual_rct",
      "difficulty": "basic",
      "question": "An cardiologist has a individual-level randomized trial . With 80% power and significance level of 0.05 using a two-sided test, What is the minimum detectable effect size?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "mdes": 0.3982
      },
      "tolerance": {
        "mdes": 0.0119
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.ira",
        "origin": "PowerUpR::mdes.ira CRAN documentation",
        "variation": "mdes_ira_n200",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmdes.ira(power=0.80, alpha=0.05, two.tailed=TRUE, n=200)",
      "tier": 3
    },
    {
      "id": "t3-pupr-008",
      "template": "cluster_rct_2level",
      "difficulty": "basic",
      "question": "An oncologist is designing a 2-level cluster randomized trial with 20 individuals per cluster. The expected effect size is 0.25. The ICC at level 2 is 0.1. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "J": 75
      },
      "tolerance": {
        "J": 4
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra2",
        "origin": "PowerUpR::mrss.cra2 CRAN documentation",
        "variation": "cra2_es25_n20_rho10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra2(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, rho2=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-009",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An neurologist is designing a 2-level cluster randomized trial with 30 individuals per cluster. The expected effect size is 0.2. The ICC at level 2 is 0.05. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "J": 66
      },
      "tolerance": {
        "J": 4
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra2",
        "origin": "PowerUpR::mrss.cra2 CRAN documentation",
        "variation": "cra2_es20_n30_rho05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra2(es=0.20, power=0.80, alpha=0.05, two.tailed=TRUE, n=30, rho2=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-010",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An psychiatrist is designing a 2-level cluster randomized trial with 20 individuals per cluster. The expected effect size is 0.25. The ICC at level 2 is 0.1. At significance level of 0.05 with 90% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "J": 100
      },
      "tolerance": {
        "J": 5
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra2",
        "origin": "PowerUpR::mrss.cra2 CRAN documentation",
        "variation": "cra2_es25_n20_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra2(es=0.25, power=0.90, alpha=0.05, two.tailed=TRUE, n=20, rho2=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-011",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An pediatrician is designing a 2-level cluster randomized trial with 20 individuals per cluster. The expected effect size is 0.25. The ICC at level 2 is 0.2. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "J": 123
      },
      "tolerance": {
        "J": 7
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra2",
        "origin": "PowerUpR::mrss.cra2 CRAN documentation",
        "variation": "cra2_es25_n20_rho20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra2(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, rho2=0.20)",
      "tier": 3
    },
    {
      "id": "t3-pupr-012",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An endocrinologist is designing a 2-level cluster randomized trial with 20 individuals per cluster. The expected effect size is 0.25. The ICC at level 2 is 0.1. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "J": 50
      },
      "tolerance": {
        "J": 3
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra2",
        "origin": "PowerUpR::mrss.cra2 CRAN documentation",
        "variation": "cra2_es25_r22_50",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra2(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, rho2=0.10, r22=0.50)",
      "tier": 3
    },
    {
      "id": "t3-pupr-013",
      "template": "cluster_rct_2level",
      "difficulty": "basic",
      "question": "An orthopedic surgeon is running a 2-level cluster randomized trial with 20 individuals per cluster. The expected effect size is 0.25. The ICC at level 2 is 0.1. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "power": 0.2848
      },
      "tolerance": {
        "power": 0.01
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra2",
        "origin": "PowerUpR::power.cra2 CRAN documentation",
        "variation": "power_cra2_J20_n20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra2(es=0.25, alpha=0.05, two.tailed=TRUE, n=20, J=20, rho2=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-014",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An gastroenterologist is running a 2-level cluster randomized trial with 30 individuals per cluster. The expected effect size is 0.25. The ICC at level 2 is 0.1. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "power": 0.5703
      },
      "tolerance": {
        "power": 0.0171
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra2",
        "origin": "PowerUpR::power.cra2 CRAN documentation",
        "variation": "power_cra2_J40_n30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra2(es=0.25, alpha=0.05, two.tailed=TRUE, n=30, J=40, rho2=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-015",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An pulmonologist has a 2-level cluster randomized trial with 20 individuals per cluster. The ICC at level 2 is 0.1. With 80% power and significance level of 0.05 using a two-sided test, What is the minimum detectable effect size?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "mdes": 0.5046
      },
      "tolerance": {
        "mdes": 0.0151
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.cra2",
        "origin": "PowerUpR::mdes.cra2 CRAN documentation",
        "variation": "mdes_cra2_J20_n20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmdes.cra2(power=0.80, alpha=0.05, two.tailed=TRUE, n=20, J=20, rho2=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-016",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An rheumatologist has a 2-level cluster randomized trial with 30 individuals per cluster. The ICC at level 2 is 0.05. With 80% power and significance level of 0.05 using a two-sided test, What is the minimum detectable effect size?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "mdes": 0.2312
      },
      "tolerance": {
        "mdes": 0.01
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.cra2",
        "origin": "PowerUpR::mdes.cra2 CRAN documentation",
        "variation": "mdes_cra2_J50_n30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmdes.cra2(power=0.80, alpha=0.05, two.tailed=TRUE, n=30, J=50, rho2=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-017",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An dermatologist is designing a individual-level randomized trial . The expected effect size is 0.25. The ICC at level 2 is 0.1. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "J": 31
      },
      "tolerance": {
        "J": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.bira2",
        "origin": "PowerUpR::mrss.bira2 CRAN documentation",
        "variation": "bira2_es25_n20_omega05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.bira2(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, rho2=0.10, omega2=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-018",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An ophthalmologist is designing a individual-level randomized trial . The expected effect size is 0.2. The ICC at level 2 is 0.05. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "J": 32
      },
      "tolerance": {
        "J": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.bira2",
        "origin": "PowerUpR::mrss.bira2 CRAN documentation",
        "variation": "bira2_es20_n30_omega05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.bira2(es=0.20, power=0.80, alpha=0.05, two.tailed=TRUE, n=30, rho2=0.05, omega2=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-019",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An nephrologist is designing a individual-level randomized trial . The expected effect size is 0.3. The ICC at level 2 is 0.1. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "J": 21
      },
      "tolerance": {
        "J": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.bira2",
        "origin": "PowerUpR::mrss.bira2 CRAN documentation",
        "variation": "bira2_es30_cov30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.bira2(es=0.30, power=0.80, alpha=0.05, two.tailed=TRUE, n=15, rho2=0.10, omega2=0.5, r21=0.30)",
      "tier": 3
    },
    {
      "id": "t3-pupr-020",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An infectious disease specialist is running a individual-level randomized trial . The expected effect size is 0.25. The ICC at level 2 is 0.1. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "power": 0.5997
      },
      "tolerance": {
        "power": 0.018
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.bira2",
        "origin": "PowerUpR::power.bira2 CRAN documentation",
        "variation": "power_bira2_J20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.bira2(es=0.25, alpha=0.05, two.tailed=TRUE, n=20, J=20, rho2=0.10, omega2=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-021",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An psychologist has a individual-level randomized trial . The ICC at level 2 is 0.1. With 80% power and significance level of 0.05 using a two-sided test, What is the minimum detectable effect size?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "mdes": 0.3168
      },
      "tolerance": {
        "mdes": 0.01
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.bira2",
        "origin": "PowerUpR::mdes.bira2 CRAN documentation",
        "variation": "mdes_bira2_J20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmdes.bira2(power=0.80, alpha=0.05, two.tailed=TRUE, n=20, J=20, rho2=0.10, omega2=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-022",
      "template": "cluster_rct_3level",
      "difficulty": "intermediate",
      "question": "An educational researcher is designing a 3-level cluster randomized trial with 20 individuals per level-2 unit and 10 level-2 units per level-3 unit. The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "K": 34
      },
      "tolerance": {
        "K": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra3",
        "origin": "PowerUpR::mrss.cra3 CRAN documentation",
        "variation": "cra3_es25_n20_J10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra3(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, J=10, rho2=0.10, rho3=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-023",
      "template": "cluster_rct_3level",
      "difficulty": "advanced",
      "question": "An epidemiologist is designing a 3-level cluster randomized trial with 15 individuals per level-2 unit and 8 level-2 units per level-3 unit. The expected effect size is 0.2. The ICC at level 2 is 0.1. The ICC at level 3 is 0.1. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "K": 96
      },
      "tolerance": {
        "K": 5
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra3",
        "origin": "PowerUpR::mrss.cra3 CRAN documentation",
        "variation": "cra3_es20_rho3_10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra3(es=0.20, power=0.80, alpha=0.05, two.tailed=TRUE, n=15, J=8, rho2=0.10, rho3=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-024",
      "template": "cluster_rct_3level",
      "difficulty": "intermediate",
      "question": "An nurse researcher is running a 3-level cluster randomized trial with 20 individuals per level-2 unit and 10 level-2 units per level-3 unit. The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "power": 0.2799
      },
      "tolerance": {
        "power": 0.01
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra3",
        "origin": "PowerUpR::power.cra3 CRAN documentation",
        "variation": "power_cra3_K10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra3(es=0.25, alpha=0.05, two.tailed=TRUE, n=20, J=10, K=10, rho2=0.10, rho3=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-025",
      "template": "cluster_rct_3level",
      "difficulty": "advanced",
      "question": "An social scientist is running a 3-level cluster randomized trial with 20 individuals per level-2 unit and 10 level-2 units per level-3 unit. The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "power": 0.7413
      },
      "tolerance": {
        "power": 0.0222
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra3",
        "origin": "PowerUpR::power.cra3 CRAN documentation",
        "variation": "power_cra3_K30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra3(es=0.25, alpha=0.05, two.tailed=TRUE, n=20, J=10, K=30, rho2=0.10, rho3=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-026",
      "template": "cluster_rct_3level",
      "difficulty": "advanced",
      "question": "An pharmacist researcher has a 3-level cluster randomized trial with 20 individuals per level-2 unit and 10 level-2 units per level-3 unit. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. With 80% power and significance level of 0.05 using a two-sided test, What is the minimum detectable effect size?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "mdes": 0.3359
      },
      "tolerance": {
        "mdes": 0.0101
      },
      "source": {
        "package": "PowerUpR",
        "function": "mdes.cra3",
        "origin": "PowerUpR::mdes.cra3 CRAN documentation",
        "variation": "mdes_cra3_K20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmdes.cra3(power=0.80, alpha=0.05, two.tailed=TRUE, n=20, J=10, K=20, rho2=0.10, rho3=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-027",
      "template": "cluster_rct_4level",
      "difficulty": "advanced",
      "question": "An gerontologist is designing a 4-level cluster randomized trial . The expected effect size is 0.25. The ICC at level 2 is 0.05. The ICC at level 3 is 0.05. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_4level",
      "ground_truth": {
        "L": 35
      },
      "tolerance": {
        "L": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra4",
        "origin": "PowerUpR::mrss.cra4 CRAN documentation",
        "variation": "cra4_es25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra4(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=10, J=5, K=5, rho2=0.05, rho3=0.05, rho4=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-028",
      "template": "cluster_rct_4level",
      "difficulty": "advanced",
      "question": "An sports medicine physician is running a 4-level cluster randomized trial . The expected effect size is 0.25. The ICC at level 2 is 0.05. The ICC at level 3 is 0.05. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_4level",
      "ground_truth": {
        "power": 0.5433
      },
      "tolerance": {
        "power": 0.0163
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra4",
        "origin": "PowerUpR::power.cra4 CRAN documentation",
        "variation": "power_cra4_L20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra4(es=0.25, alpha=0.05, two.tailed=TRUE, n=10, J=5, K=5, L=20, rho2=0.05, rho3=0.05, rho4=0.05)",
      "tier": 3
    },
    {
      "id": "t3-pupr-029",
      "template": "individual_rct",
      "difficulty": "advanced",
      "question": "An allergist is designing a individual-level randomized trial . The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "K": 8
      },
      "tolerance": {
        "K": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.bira3",
        "origin": "PowerUpR::mrss.bira3 CRAN documentation",
        "variation": "bira3_es25_omega05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.bira3(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, J=10, rho2=0.10, rho3=0.05, omega2=0.5, omega3=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-030",
      "template": "individual_rct",
      "difficulty": "advanced",
      "question": "An urologist is running a individual-level randomized trial . The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "power": 0.8993
      },
      "tolerance": {
        "power": 0.027
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.bira3",
        "origin": "PowerUpR::power.bira3 CRAN documentation",
        "variation": "power_bira3_K10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.bira3(es=0.25, alpha=0.05, two.tailed=TRUE, n=20, J=10, K=10, rho2=0.10, rho3=0.05, omega2=0.5, omega3=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-031",
      "template": "cluster_rct_3level",
      "difficulty": "advanced",
      "question": "An hematologist is designing a 3-level cluster randomized trial with 20 individuals per level-2 unit and 10 level-2 units per level-3 unit. The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "K": 12
      },
      "tolerance": {
        "K": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.bcra3r2",
        "origin": "PowerUpR::mrss.bcra3r2 CRAN documentation",
        "variation": "bcra3r2_es25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.bcra3r2(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=20, J=10, rho2=0.10, rho3=0.05, omega3=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-032",
      "template": "cluster_rct_3level",
      "difficulty": "advanced",
      "question": "An clinical nutritionist is running a 3-level cluster randomized trial with 20 individuals per level-2 unit and 10 level-2 units per level-3 unit. The expected effect size is 0.25. The ICC at level 2 is 0.1. The ICC at level 3 is 0.05. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_3level",
      "ground_truth": {
        "power": 0.8814
      },
      "tolerance": {
        "power": 0.0264
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.bcra3r2",
        "origin": "PowerUpR::power.bcra3r2 CRAN documentation",
        "variation": "power_bcra3r2_K15",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.bcra3r2(es=0.25, alpha=0.05, two.tailed=TRUE, n=20, J=10, K=15, rho2=0.10, rho3=0.05, omega3=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-033",
      "template": "partially_nested_rct",
      "difficulty": "advanced",
      "question": "An rehabilitation specialist is designing a 2-level partially nested cluster randomized trial . The expected effect size is 0.25. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "partially_nested_rct",
      "ground_truth": {
        "J": 82
      },
      "tolerance": {
        "J": 5
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.cra2_pn",
        "origin": "PowerUpR::mrss.cra2_pn CRAN documentation",
        "variation": "pn_cra2_es25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.cra2_pn(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=15, rho2_trt=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-034",
      "template": "partially_nested_rct",
      "difficulty": "advanced",
      "question": "An occupational therapist is running a 2-level partially nested cluster randomized trial . The expected effect size is 0.25. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "partially_nested_rct",
      "ground_truth": {
        "power": 0.5814
      },
      "tolerance": {
        "power": 0.0174
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra2_pn",
        "origin": "PowerUpR::power.cra2_pn CRAN documentation",
        "variation": "power_pn_cra2_J50",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra2_pn(es=0.25, alpha=0.05, two.tailed=TRUE, n=15, J=50, rho2_trt=0.10)",
      "tier": 3
    },
    {
      "id": "t3-pupr-035",
      "template": "individual_rct",
      "difficulty": "advanced",
      "question": "An speech pathologist is designing a individual-level randomized trial . The expected effect size is 0.25. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "J": 38
      },
      "tolerance": {
        "J": 2
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.bira2_pn",
        "origin": "PowerUpR::mrss.bira2_pn CRAN documentation",
        "variation": "pn_bira2_es25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.bira2_pn(es=0.25, power=0.80, alpha=0.05, two.tailed=TRUE, n=15, rho2_trt=0.10, omega2=0.5)",
      "tier": 3
    },
    {
      "id": "t3-pupr-036",
      "template": "individual_rct",
      "difficulty": "intermediate",
      "question": "An physical therapist is designing a individual-level randomized trial . The expected effect size is 0.15. At significance level of 0.05 with 80% power using a two-sided test, how many top-level units (e.g., schools, clinics) are needed?",
      "expected_template": "individual_rct",
      "ground_truth": {
        "n": 1397
      },
      "tolerance": {
        "n": 70
      },
      "source": {
        "package": "PowerUpR",
        "function": "mrss.ira",
        "origin": "PowerUpR::mrss.ira CRAN documentation",
        "variation": "ira_es15_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\nmrss.ira(es=0.15, power=0.80, alpha=0.05, two.tailed=TRUE)",
      "tier": 3
    },
    {
      "id": "t3-pupr-037",
      "template": "cluster_rct_2level",
      "difficulty": "intermediate",
      "question": "An cardiologist is running a 2-level cluster randomized trial with 25 individuals per cluster. The expected effect size is 0.2. The ICC at level 2 is 0.15. What power will a two-sided test achieve at significance level of 0.05?",
      "expected_template": "cluster_rct_2level",
      "ground_truth": {
        "power": 0.2946
      },
      "tolerance": {
        "power": 0.01
      },
      "source": {
        "package": "PowerUpR",
        "function": "power.cra2",
        "origin": "PowerUpR::power.cra2 CRAN documentation",
        "variation": "power_cra2_cov",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerUpR)\npower.cra2(es=0.20, alpha=0.05, two.tailed=TRUE, n=25, J=30, rho2=0.15, r22=0.30)",
      "tier": 3
    },
    {
      "id": "t3-sp-012",
      "template": "mixed_design",
      "difficulty": "intermediate",
      "question": "A gastroenterologist is conducting a mixed factorial study (2b*2w) with 40 participants per cell measuring fatigue severity scores with correlation 0.5 between repeated measures. What power does the study have for main effects and interactions at significance level of 0.05?",
      "expected_template": "mixed_design",
      "ground_truth": {
        "power_a": 0.2473,
        "power_b": 0.5981,
        "power_a_b": 0.5981
      },
      "tolerance": {
        "power_a": 0.02,
        "power_b": 0.0299,
        "power_a_b": 0.0299
      },
      "source": {
        "package": "Superpower",
        "function": "ANOVA_exact",
        "origin": "Superpower::ANOVA_exact CRAN documentation",
        "variation": "2b2w_n40_r05_interaction",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(Superpower)\n{ d <- ANOVA_design(design=\"2b*2w\", n=40, mu=c(0, 0.5, 0, 0), sd=1, r=0.5, plot=FALSE); ANOVA_exact(d, verbose=FALSE) }",
      "tier": 3
    },
    {
      "id": "t3-sp-013",
      "template": "mixed_design",
      "difficulty": "advanced",
      "question": "A pulmonologist is conducting a mixed factorial study (2b*3w) with 30 participants per cell measuring attention scores with correlation 0.5 between repeated measures. What power does the study have for main effects and interactions at significance level of 0.05?",
      "expected_template": "mixed_design",
      "ground_truth": {
        "power_a": 0.1541,
        "power_b": 0.7874,
        "power_a_b": 0.258
      },
      "tolerance": {
        "power_a": 0.02,
        "power_b": 0.0394,
        "power_a_b": 0.02
      },
      "source": {
        "package": "Superpower",
        "function": "ANOVA_exact",
        "origin": "Superpower::ANOVA_exact CRAN documentation",
        "variation": "2b3w_n30_r05_differential",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(Superpower)\n{ d <- ANOVA_design(design=\"2b*3w\", n=30, mu=c(0, 0.3, 0.6, 0, 0.1, 0.2), sd=1, r=0.5, plot=FALSE); ANOVA_exact(d, verbose=FALSE) }",
      "tier": 3
    },
    {
      "id": "t3-sp-014",
      "template": "mixed_design",
      "difficulty": "intermediate",
      "question": "A rheumatologist is conducting a mixed factorial study (2b*2w) with 60 participants per cell measuring motor function scores with correlation 0.5 between repeated measures. What power does the study have for main effects and interactions at significance level of 0.05?",
      "expected_template": "mixed_design",
      "ground_truth": {
        "power_a": 0.469,
        "power_b": 0.9031,
        "power_a_b": 0.05
      },
      "tolerance": {
        "power_a": 0.0234,
        "power_b": 0.0452,
        "power_a_b": 0.02
      },
      "source": {
        "package": "Superpower",
        "function": "ANOVA_exact",
        "origin": "Superpower::ANOVA_exact CRAN documentation",
        "variation": "2b2w_n60_additive",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(Superpower)\n{ d <- ANOVA_design(design=\"2b*2w\", n=60, mu=c(0, 0.3, 0.3, 0.6), sd=1, r=0.5, plot=FALSE); ANOVA_exact(d, verbose=FALSE) }",
      "tier": 3
    },
    {
      "id": "t3-sp-015",
      "template": "factorial_design",
      "difficulty": "advanced",
      "question": "A dermatologist has 50 participants per cell in a 2 x 2 x 2 factorial design studying symptom severity scores with cell means (0.0, 0.0, 0.0, 0.5, 0.0, 0.0, 0.0, 0.0) with SD = 1. What power is achieved for main effects and interactions at significance level of 0.05?",
      "expected_template": "factorial_design",
      "ground_truth": {
        "power_a": 0.2386,
        "power_b": 0.2386,
        "power_c": 0.2386,
        "power_a_b": 0.2386,
        "power_a_c": 0.2386,
        "power_b_c": 0.2386,
        "power_a_b_c": 0.2386
      },
      "tolerance": {
        "power_a": 0.02,
        "power_b": 0.02,
        "power_c": 0.02,
        "power_a_b": 0.02,
        "power_a_c": 0.02,
        "power_b_c": 0.02,
        "power_a_b_c": 0.02
      },
      "source": {
        "package": "Superpower",
        "function": "ANOVA_exact",
        "origin": "Superpower::ANOVA_exact CRAN documentation",
        "variation": "2x2x2b_n50_3way_int",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(Superpower)\n{ d <- ANOVA_design(design=\"2b*2b*2b\", n=50, mu=c(0, 0, 0, 0.5, 0, 0, 0, 0), sd=1, plot=FALSE); ANOVA_exact(d, verbose=FALSE) }",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-001",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A ophthalmologist is planning a fixed-sample clinical trial for type 2 diabetes. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 91
      },
      "tolerance": {
        "sample_size": 5
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d1_sd17_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=1, sd=1.7, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-002",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A nephrologist is planning a fixed-sample clinical trial for major depressive disorder. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 126
      },
      "tolerance": {
        "sample_size": 7
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d05_sd1_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=0.5, sd=1.0, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-003",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A infectious disease specialist is planning a fixed-sample clinical trial for chronic pain. At significance level of 0.05 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 126
      },
      "tolerance": {
        "sample_size": 7
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d1_sd2_2sided",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=1, sd=2.0, alpha=0.05, beta=0.20, sided=2)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-004",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A psychologist is planning a fixed-sample clinical trial for asthma. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 349
      },
      "tolerance": {
        "sample_size": 18
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d03_sd1",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=0.3, sd=1.0, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-005",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A educational researcher is planning a fixed-sample clinical trial for COPD. At significance level of 0.025 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 122
      },
      "tolerance": {
        "sample_size": 7
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d1_sd17_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=1, sd=1.7, alpha=0.025, beta=0.10, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-006",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A epidemiologist is planning a fixed-sample clinical trial for rheumatoid arthritis. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 423
      },
      "tolerance": {
        "sample_size": 22
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d03_2sided",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=0.3, sd=1.0, alpha=0.025, beta=0.20, sided=2)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-007",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A nurse researcher is planning a fixed-sample clinical trial for breast cancer. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 103
      },
      "tolerance": {
        "sample_size": 6
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d1_ratio2",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=1, sd=1.7, alpha=0.025, beta=0.20, ratio=2, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-008",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A social scientist is planning a fixed-sample clinical trial for heart failure. At significance level of 0.025 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 379
      },
      "tolerance": {
        "sample_size": 19
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d05_sd15_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=0.5, sd=1.5, alpha=0.025, beta=0.10, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-009",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A pharmacist researcher is planning a fixed-sample clinical trial for Alzheimer's disease. At significance level of 0.01 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 953
      },
      "tolerance": {
        "sample_size": 48
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d025_alpha01_p90_2s",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=0.25, sd=1.0, alpha=0.01, beta=0.10, sided=2)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-010",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A gerontologist is planning a fixed-sample clinical trial for Parkinson's disease. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 262
      },
      "tolerance": {
        "sample_size": 14
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d2_sd5_ratio3",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=2, sd=5, alpha=0.025, beta=0.20, ratio=3, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-011",
      "template": "fixed_design",
      "difficulty": "advanced",
      "question": "A sports medicine physician is planning a fixed-sample clinical trial for multiple sclerosis. At significance level of 0.025 with 95% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 1300
      },
      "tolerance": {
        "sample_size": 65
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d01_sd05_p95",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=0.1, sd=0.5, alpha=0.025, beta=0.05, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nnormal-012",
      "template": "fixed_design",
      "difficulty": "advanced",
      "question": "A allergist is planning a fixed-sample clinical trial for chronic kidney disease. At significance level of 0.005 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 154
      },
      "tolerance": {
        "sample_size": 8
      },
      "source": {
        "package": "gsDesign",
        "function": "nNormal",
        "origin": "gsDesign::nNormal CRAN documentation",
        "variation": "nnorm_d1_alpha005_2s",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnNormal(delta1=1, sd=1.7, alpha=0.005, beta=0.20, sided=2)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-013",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A urologist is planning a fixed-sample clinical trial for inflammatory bowel disease. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 1372
      },
      "tolerance": {
        "sample_size": 69
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_15v10_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.15, p2=0.10, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-014",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A hematologist is planning a fixed-sample clinical trial for migraine. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 398
      },
      "tolerance": {
        "sample_size": 20
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_20v10_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.20, p2=0.10, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-015",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A clinical nutritionist is planning a fixed-sample clinical trial for generalized anxiety disorder. At significance level of 0.05 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 775
      },
      "tolerance": {
        "sample_size": 39
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_50v40_2sided",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.50, p2=0.40, alpha=0.05, beta=0.20, sided=2)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-016",
      "template": "fixed_design",
      "difficulty": "basic",
      "question": "A rehabilitation specialist is planning a fixed-sample clinical trial for osteoarthritis. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 500
      },
      "tolerance": {
        "sample_size": 25
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_25v15",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.25, p2=0.15, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-017",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A occupational therapist is planning a fixed-sample clinical trial for atrial fibrillation. At significance level of 0.025 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 784
      },
      "tolerance": {
        "sample_size": 40
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_30v20_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.30, p2=0.20, alpha=0.025, beta=0.10, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-018",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A speech pathologist is planning a fixed-sample clinical trial for psoriasis. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 1506
      },
      "tolerance": {
        "sample_size": 76
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_15v10_ratio2",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.15, p2=0.10, alpha=0.025, beta=0.20, ratio=2, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-019",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A physical therapist is planning a fixed-sample clinical trial for epilepsy. At significance level of 0.025 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 953
      },
      "tolerance": {
        "sample_size": 48
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_40v30_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.40, p2=0.30, alpha=0.025, beta=0.10, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-020",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A cardiologist is planning a fixed-sample clinical trial for hypertension. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 869
      },
      "tolerance": {
        "sample_size": 44
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_10v05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.10, p2=0.05, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-021",
      "template": "fixed_design",
      "difficulty": "intermediate",
      "question": "A oncologist is planning a fixed-sample clinical trial for type 2 diabetes. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 874
      },
      "tolerance": {
        "sample_size": 44
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_60v50_ratio2",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.60, p2=0.50, alpha=0.025, beta=0.20, ratio=2, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-022",
      "template": "fixed_design",
      "difficulty": "advanced",
      "question": "A neurologist is planning a fixed-sample clinical trial for major depressive disorder. At significance level of 0.01 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 2599
      },
      "tolerance": {
        "sample_size": 130
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_15v10_alpha01_2s_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.15, p2=0.10, alpha=0.01, beta=0.10, sided=2)",
      "tier": 3
    },
    {
      "id": "t3-gs-nbinomial-023",
      "template": "fixed_design",
      "difficulty": "advanced",
      "question": "A psychiatrist is planning a fixed-sample clinical trial for chronic pain. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design",
      "ground_truth": {
        "sample_size": 498
      },
      "tolerance": {
        "sample_size": 25
      },
      "source": {
        "package": "gsDesign",
        "function": "nBinomial",
        "origin": "gsDesign::nBinomial CRAN documentation",
        "variation": "nbin_20v10_ratio3",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnBinomial(p1=0.20, p2=0.10, alpha=0.025, beta=0.20, ratio=3, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-024",
      "template": "fixed_design_survival",
      "difficulty": "intermediate",
      "question": "A pediatrician is planning a fixed-sample clinical trial for a time-to-event endpoint for asthma. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 289,
        "events": 191
      },
      "tolerance": {
        "total_sample_size": 15,
        "events": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med12v18_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/12, lambda2=log(2)/18, eta=0, Ts=36, Tr=24, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-025",
      "template": "fixed_design_survival",
      "difficulty": "intermediate",
      "question": "A endocrinologist is planning a fixed-sample clinical trial for a time-to-event endpoint for COPD. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 289,
        "events": 191
      },
      "tolerance": {
        "total_sample_size": 15,
        "events": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med10v15_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/10, lambda2=log(2)/15, eta=0, Ts=30, Tr=20, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-026",
      "template": "fixed_design_survival",
      "difficulty": "intermediate",
      "question": "A orthopedic surgeon is planning a fixed-sample clinical trial for a time-to-event endpoint for rheumatoid arthritis. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 302,
        "events": 191
      },
      "tolerance": {
        "total_sample_size": 16,
        "events": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med8v12_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/8, lambda2=log(2)/12, eta=0, Ts=24, Tr=18, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-027",
      "template": "fixed_design_survival",
      "difficulty": "intermediate",
      "question": "A gastroenterologist is planning a fixed-sample clinical trial for a time-to-event endpoint for breast cancer. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 237,
        "events": 190
      },
      "tolerance": {
        "total_sample_size": 12,
        "events": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med6v9_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/6, lambda2=log(2)/9, eta=0, Ts=24, Tr=12, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-028",
      "template": "fixed_design_survival",
      "difficulty": "advanced",
      "question": "A pulmonologist is planning a fixed-sample clinical trial for a time-to-event endpoint for heart failure. At significance level of 0.025 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 387,
        "events": 255
      },
      "tolerance": {
        "total_sample_size": 20,
        "events": 13
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med12v18_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/12, lambda2=log(2)/18, eta=0, Ts=36, Tr=24, alpha=0.025, beta=0.10, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-029",
      "template": "fixed_design_survival",
      "difficulty": "advanced",
      "question": "A rheumatologist is planning a fixed-sample clinical trial for a time-to-event endpoint for Alzheimer's disease. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 318,
        "events": 191
      },
      "tolerance": {
        "total_sample_size": 16,
        "events": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med12v18_dropout",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/12, lambda2=log(2)/18, eta=0.01, Ts=36, Tr=24, alpha=0.025, beta=0.20, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-030",
      "template": "fixed_design_survival",
      "difficulty": "advanced",
      "question": "A dermatologist is planning a fixed-sample clinical trial for a time-to-event endpoint for Parkinson's disease. At significance level of 0.025 with 80% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 330,
        "events": 210
      },
      "tolerance": {
        "total_sample_size": 17,
        "events": 11
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med12v18_ratio2",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/12, lambda2=log(2)/18, eta=0, Ts=36, Tr=24, alpha=0.025, beta=0.20, ratio=2, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-nsurvival-031",
      "template": "fixed_design_survival",
      "difficulty": "advanced",
      "question": "A ophthalmologist is planning a fixed-sample clinical trial for a time-to-event endpoint for multiple sclerosis. At significance level of 0.025 with 90% power, what maximum sample size is required?",
      "expected_template": "fixed_design_survival",
      "ground_truth": {
        "total_sample_size": 297,
        "events": 190
      },
      "tolerance": {
        "total_sample_size": 15,
        "events": 10
      },
      "source": {
        "package": "gsDesign",
        "function": "nSurvival",
        "origin": "gsDesign::nSurvival CRAN documentation",
        "variation": "nsurv_med15v24_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\nnSurvival(lambda1=log(2)/15, lambda2=log(2)/24, eta=0, Ts=48, Tr=36, alpha=0.025, beta=0.10, sided=1)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-032",
      "template": "group_sequential",
      "difficulty": "intermediate",
      "question": "A nephrologist is planning a group sequential design with 2 analyses for chronic kidney disease. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0037,
        "inflation_factor": 1.0037,
        "analyses": 2,
        "upper_bounds": [
          2.9626,
          1.9686
        ],
        "power": 0.8
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_2look_1sided_LDOF",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=2, test.type=1, alpha=0.025, beta=0.20, sfu=sfLDOF)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-033",
      "template": "group_sequential",
      "difficulty": "intermediate",
      "question": "A infectious disease specialist is planning a group sequential design with 2 analyses for inflammatory bowel disease. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.1226,
        "inflation_factor": 1.1226,
        "analyses": 2,
        "upper_bounds": [
          2.157,
          2.201
        ],
        "power": 0.8
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_2look_1sided_Pocock",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=2, test.type=1, alpha=0.025, beta=0.20, sfu=sfLDPocock)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-034",
      "template": "group_sequential",
      "difficulty": "intermediate",
      "question": "A psychologist is planning a group sequential design with 3 analyses for migraine. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0128,
        "inflation_factor": 1.0128,
        "analyses": 3,
        "upper_bounds": [
          3.7103,
          2.5114,
          1.993
        ],
        "power": 0.8
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_1sided_LDOF",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=1, alpha=0.025, beta=0.20, sfu=sfLDOF)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-035",
      "template": "group_sequential",
      "difficulty": "intermediate",
      "question": "A educational researcher is planning a group sequential design with 3 analyses for generalized anxiety disorder. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.1704,
        "inflation_factor": 1.1704,
        "analyses": 3,
        "upper_bounds": [
          2.2794,
          2.2949,
          2.2959
        ],
        "power": 0.8
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_1sided_Pocock",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=1, alpha=0.025, beta=0.20, sfu=sfLDPocock)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-036",
      "template": "group_sequential",
      "difficulty": "intermediate",
      "question": "A epidemiologist is planning a group sequential design with 3 analyses for osteoarthritis. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0203,
        "inflation_factor": 1.0203,
        "analyses": 3,
        "upper_bounds": [
          3.2001,
          2.1408,
          1.6948
        ],
        "power": 0.8,
        "lower_bounds": [
          -3.2001,
          -2.1408,
          -1.6948
        ]
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_2sided_LDOF",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=2, alpha=0.05, beta=0.20, sfu=sfLDOF)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-037",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A nurse researcher is planning a group sequential design with 3 analyses for atrial fibrillation. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0699,
        "inflation_factor": 1.0699,
        "analyses": 3,
        "upper_bounds": [
          3.0107,
          2.5465,
          1.9992
        ],
        "power": 0.9,
        "lower_bounds": [
          -0.2387,
          0.9411,
          1.9992
        ]
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.027
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_HSD_futility_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=4, alpha=0.025, beta=0.10, sfu=sfHSD, sfupar=-4, sfl=sfHSD, sflpar=-2)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-038",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A social scientist is planning a group sequential design with 3 analyses for psoriasis. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0413,
        "inflation_factor": 1.0413,
        "analyses": 3,
        "upper_bounds": [
          3.7103,
          2.5111,
          1.9584
        ],
        "power": 0.8,
        "lower_bounds": [
          -0.2352,
          0.8959,
          1.9584
        ]
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_nonbind_futility",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=3, alpha=0.025, beta=0.20, sfu=sfLDOF, sfl=sfHSD, sflpar=-2)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-039",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A pharmacist researcher is planning a group sequential design with 4 analyses for epilepsy. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0399,
        "inflation_factor": 1.0399,
        "analyses": 4,
        "upper_bounds": [
          4.3326,
          2.9631,
          2.359,
          2.0141
        ],
        "power": 0.8,
        "lower_bounds": [
          -1.0602,
          -0.0249,
          0.9514,
          2.0141
        ]
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_4look_bind_futility",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=4, test.type=4, alpha=0.025, beta=0.20, sfu=sfLDOF, sfl=sfHSD, sflpar=-4)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-040",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A gerontologist is planning a group sequential design with 2 analyses for hypertension. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0423,
        "inflation_factor": 1.0423,
        "analyses": 2,
        "upper_bounds": [
          2.75,
          1.9811
        ],
        "power": 0.8,
        "lower_bounds": [
          0.4133,
          1.9811
        ]
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_2look_HSD_bind_futility",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=2, test.type=4, alpha=0.025, beta=0.20, sfu=sfHSD, sfupar=-4, sfl=sfHSD, sflpar=-2)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-041",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A sports medicine physician is planning a group sequential design with 5 analyses for type 2 diabetes. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0247,
        "inflation_factor": 1.0247,
        "analyses": 5,
        "upper_bounds": [
          4.8769,
          3.357,
          2.6803,
          2.2898,
          2.031
        ],
        "power": 0.8
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_5look_LDOF",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=5, test.type=1, alpha=0.025, beta=0.20, sfu=sfLDOF)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-042",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A allergist is planning a group sequential design with 3 analyses for major depressive disorder. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.1364,
        "inflation_factor": 1.1364,
        "analyses": 3,
        "upper_bounds": [
          2.6775,
          2.3854,
          2.0637
        ],
        "power": 0.8,
        "lower_bounds": [
          0.0399,
          1.1028,
          2.0637
        ]
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.024
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_HSD_m2_m1",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=4, alpha=0.025, beta=0.20, sfu=sfHSD, sfupar=-2, sfl=sfHSD, sflpar=-1)",
      "tier": 3
    },
    {
      "id": "t3-gs-gsdesign-043",
      "template": "group_sequential",
      "difficulty": "advanced",
      "question": "A urologist is planning a group sequential design with 3 analyses for chronic pain. What is the statistical power?",
      "expected_template": "group_sequential",
      "ground_truth": {
        "n_fix": 1,
        "max_info_ratio": 1.0067,
        "inflation_factor": 1.0067,
        "analyses": 3,
        "upper_bounds": [
          4.3106,
          2.9472,
          2.3461
        ],
        "power": 0.9
      },
      "tolerance": {
        "n_fix": 2,
        "max_info_ratio": 2,
        "inflation_factor": 2,
        "analyses": 2,
        "power": 0.027
      },
      "source": {
        "package": "gsDesign",
        "function": "gsDesign",
        "origin": "gsDesign::gsDesign CRAN documentation",
        "variation": "gsd_3look_alpha01_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(gsDesign)\ngsDesign(k=3, test.type=1, alpha=0.01, beta=0.10, sfu=sfLDOF)",
      "tier": 3
    },
    {
      "id": "t3-ptost-001",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.1. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 8,
        "power": 0.9155
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0275
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv10_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.10, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-002",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.15. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 12,
        "power": 0.8305
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0249
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv15_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.15, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-003",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 20,
        "power": 0.8347
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.025
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv20_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.20, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-004",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 28,
        "power": 0.8074
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv25_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.25, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-005",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 40,
        "power": 0.8158
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv30_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-006",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.35. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 52,
        "power": 0.8075
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv35_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.35, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-007",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 66,
        "power": 0.8053
      },
      "tolerance": {
        "sample_size": 4,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv40_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-008",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 26,
        "power": 0.9176
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0275
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv20_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.90, CV=0.20, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-009",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 38,
        "power": 0.9089
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0273
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv25_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.90, CV=0.25, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-010",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 52,
        "power": 0.902
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0271
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv30_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.90, CV=0.30, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-011",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.85. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 206,
        "power": 0.8011
      },
      "tolerance": {
        "sample_size": 11,
        "power": 0.024
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv25_t085",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.25, theta0=0.85, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-012",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 56,
        "power": 0.8036
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv25_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.25, theta0=0.90, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-013",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 1.0. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 24,
        "power": 0.8372
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0251
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv25_t100",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.25, theta0=1.00, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-014",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2 crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 1.05. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 28,
        "power": 0.8163
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_2x2_cv25_t105",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.25, theta0=1.05, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-015",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a parallel crossover design. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 36,
        "power": 0.8099
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0243
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_parallel_cv20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.20, theta0=0.95, design=\"parallel\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-016",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a parallel crossover design. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 54,
        "power": 0.8039
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_parallel_cv25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.25, theta0=0.95, design=\"parallel\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-017",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a parallel crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 76,
        "power": 0.8031
      },
      "tolerance": {
        "sample_size": 4,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_parallel_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.95, design=\"parallel\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-018",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a parallel crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 130,
        "power": 0.8035
      },
      "tolerance": {
        "sample_size": 7,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_parallel_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"parallel\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-019",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2x3 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 30,
        "power": 0.8204
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_223_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.95, design=\"2x2x3\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-020",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2x3 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 50,
        "power": 0.8119
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0244
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_223_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"2x2x3\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-021",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 20,
        "power": 0.8202
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_224_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.95, design=\"2x2x4\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-022",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 34,
        "power": 0.8193
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_224_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"2x2x4\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-023",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 30,
        "power": 0.8204
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_233_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.95, design=\"2x3x3\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-024",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a average bioequivalence (TOST) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "sample_size": 51,
        "power": 0.8194
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.TOST",
        "origin": "PowerTOST::sampleN.TOST CRAN docs / direct computation",
        "variation": "tost_233_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.TOST(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"2x3x3\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-025",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 20 participants per group. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8347
      },
      "tolerance": {
        "power": 0.025
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n20_cv20_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=20, CV=0.20, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-026",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 24 participants per group. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.896
      },
      "tolerance": {
        "power": 0.0269
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n24_cv20_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=24, CV=0.20, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-027",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 26 participants per group. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.7761
      },
      "tolerance": {
        "power": 0.0233
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n26_cv25_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=26, CV=0.25, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-028",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 30 participants per group. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8343
      },
      "tolerance": {
        "power": 0.025
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n30_cv25_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=30, CV=0.25, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-029",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 36 participants per group. The within-subject coefficient of variation (CV) is 0.25. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8941
      },
      "tolerance": {
        "power": 0.0268
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n36_cv25_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=36, CV=0.25, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-030",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 40 participants per group. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8158
      },
      "tolerance": {
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n40_cv30_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=40, CV=0.30, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-031",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 48 participants per group. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.879
      },
      "tolerance": {
        "power": 0.0264
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n48_cv30_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=48, CV=0.30, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-032",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 60 participants per group. The within-subject coefficient of variation (CV) is 0.35. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8593
      },
      "tolerance": {
        "power": 0.0258
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n60_cv35_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=60, CV=0.35, theta0=0.95, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-033",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 24 participants per group. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.6373
      },
      "tolerance": {
        "power": 0.0191
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n24_cv20_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=24, CV=0.20, theta0=0.90, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-034",
      "template": "bioequivalence_tost",
      "difficulty": "basic",
      "question": "A average bioequivalence (TOST) study uses a 2x2 crossover design with 36 participants per group. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 1.0. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8702
      },
      "tolerance": {
        "power": 0.0261
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2_n36_cv30_t100",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=36, CV=0.30, theta0=1.00, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-035",
      "template": "bioequivalence_tost",
      "difficulty": "intermediate",
      "question": "A average bioequivalence (TOST) study uses a parallel crossover design with 40 participants per group. The within-subject coefficient of variation (CV) is 0.2. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8492
      },
      "tolerance": {
        "power": 0.0255
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_parallel_n40_cv20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=40, CV=0.20, theta0=0.95, design=\"parallel\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-036",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A average bioequivalence (TOST) study uses a 2x2x4 crossover design with 24 participants per group. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8819
      },
      "tolerance": {
        "power": 0.0265
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x2x4_n24_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=24, CV=0.30, theta0=0.95, design=\"2x2x4\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-037",
      "template": "bioequivalence_tost",
      "difficulty": "advanced",
      "question": "A average bioequivalence (TOST) study uses a 2x3x3 crossover design with 30 participants per group. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_tost",
      "ground_truth": {
        "power": 0.8204
      },
      "tolerance": {
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.TOST",
        "origin": "PowerTOST::power.TOST CRAN docs / direct computation",
        "variation": "power_2x3x3_n30_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.TOST(alpha=0.05, n=30, CV=0.30, theta0=0.95, design=\"2x3x3\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-038",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 54,
        "power": 0.8159
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_233_cv30_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-039",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 42,
        "power": 0.8006
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.024
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_233_cv40_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-040",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 39,
        "power": 0.8076
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_233_cv50_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.50, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-041",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.6. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 48,
        "power": 0.8176
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_233_cv60_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.60, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-042",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 27,
        "power": 0.8004
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.024
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_233_cv40_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-043",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 30,
        "power": 0.826
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0248
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_233_cv50_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.50, theta0=0.95, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-044",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 30,
        "power": 0.8066
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_224_cv40_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.90, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-045",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 28,
        "power": 0.8143
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0244
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_224_cv50_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.50, theta0=0.90, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-046",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.45. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 20,
        "power": 0.8175
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.scABEL",
        "origin": "PowerTOST::sampleN.scABEL CRAN docs / direct computation",
        "variation": "scabel_224_cv45_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.scABEL(alpha=0.05, targetpower=0.80, CV=0.45, theta0=0.95, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-047",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x3x3 crossover design with 36 participants per group. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.7452
      },
      "tolerance": {
        "power": 0.0224
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.scABEL",
        "origin": "PowerTOST::power.scABEL CRAN docs / direct computation",
        "variation": "pscabel_233_n36_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.scABEL(alpha=0.05, n=36, CV=0.40, theta0=0.90, design=\"2x3x3\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-048",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x3x3 crossover design with 42 participants per group. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.8006
      },
      "tolerance": {
        "power": 0.024
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.scABEL",
        "origin": "PowerTOST::power.scABEL CRAN docs / direct computation",
        "variation": "pscabel_233_n42_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.scABEL(alpha=0.05, n=42, CV=0.40, theta0=0.90, design=\"2x3x3\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-049",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x3x3 crossover design with 48 participants per group. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.8784
      },
      "tolerance": {
        "power": 0.0264
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.scABEL",
        "origin": "PowerTOST::power.scABEL CRAN docs / direct computation",
        "variation": "pscabel_233_n48_cv50",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.scABEL(alpha=0.05, n=48, CV=0.50, theta0=0.90, design=\"2x3x3\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-050",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x2x4 crossover design with 36 participants per group. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.863
      },
      "tolerance": {
        "power": 0.0259
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.scABEL",
        "origin": "PowerTOST::power.scABEL CRAN docs / direct computation",
        "variation": "pscabel_224_n36_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.scABEL(alpha=0.05, n=36, CV=0.40, theta0=0.90, design=\"2x2x4\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-051",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 33,
        "power": 0.8084
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0243
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE CRAN docs / direct computation",
        "variation": "rsabe_233_cv40_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.RSABE(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-052",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 30,
        "power": 0.8023
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE CRAN docs / direct computation",
        "variation": "rsabe_233_cv50_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.RSABE(alpha=0.05, targetpower=0.80, CV=0.50, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-053",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.6. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 33,
        "power": 0.8171
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE CRAN docs / direct computation",
        "variation": "rsabe_233_cv60_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.RSABE(alpha=0.05, targetpower=0.80, CV=0.60, theta0=0.90, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-054",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x3x3 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 24,
        "power": 0.8086
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0243
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE CRAN docs / direct computation",
        "variation": "rsabe_233_cv40_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.RSABE(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.95, design=\"2x3x3\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-055",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 24,
        "power": 0.8052
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE CRAN docs / direct computation",
        "variation": "rsabe_224_cv40_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.RSABE(alpha=0.05, targetpower=0.80, CV=0.40, theta0=0.90, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-056",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a reference-scaled average bioequivalence (RSABE) study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.9. What is the statistical power?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "sample_size": 22,
        "power": 0.8027
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.RSABE",
        "origin": "PowerTOST::sampleN.RSABE CRAN docs / direct computation",
        "variation": "rsabe_224_cv50_t090",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.RSABE(alpha=0.05, targetpower=0.80, CV=0.50, theta0=0.90, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-057",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x3x3 crossover design with 30 participants per group. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.7729
      },
      "tolerance": {
        "power": 0.0232
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.RSABE",
        "origin": "PowerTOST::power.RSABE CRAN docs / direct computation",
        "variation": "prsabe_233_n30_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.RSABE(alpha=0.05, n=30, CV=0.40, theta0=0.90, design=\"2x3x3\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-058",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x3x3 crossover design with 42 participants per group. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.8842
      },
      "tolerance": {
        "power": 0.0265
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.RSABE",
        "origin": "PowerTOST::power.RSABE CRAN docs / direct computation",
        "variation": "prsabe_233_n42_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.RSABE(alpha=0.05, n=42, CV=0.40, theta0=0.90, design=\"2x3x3\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-059",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x3x3 crossover design with 42 participants per group. The within-subject coefficient of variation (CV) is 0.5. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.8897
      },
      "tolerance": {
        "power": 0.0267
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.RSABE",
        "origin": "PowerTOST::power.RSABE CRAN docs / direct computation",
        "variation": "prsabe_233_n42_cv50",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.RSABE(alpha=0.05, n=42, CV=0.50, theta0=0.90, design=\"2x3x3\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-060",
      "template": "bioequivalence_scaled",
      "difficulty": "advanced",
      "question": "A reference-scaled average bioequivalence (RSABE) study uses a 2x2x4 crossover design with 36 participants per group. The within-subject coefficient of variation (CV) is 0.4. The expected geometric mean ratio (test/reference) is 0.9. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_scaled",
      "ground_truth": {
        "power": 0.9226
      },
      "tolerance": {
        "power": 0.0277
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.RSABE",
        "origin": "PowerTOST::power.RSABE CRAN docs / direct computation",
        "variation": "prsabe_224_n36_cv40",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.RSABE(alpha=0.05, n=36, CV=0.40, theta0=0.90, design=\"2x2x4\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-061",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A neurologist is designing a non-inferiority trial for major depressive disorder using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 24,
        "power": 0.8193
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_a025_cv20_t095_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.025, targetpower=0.80, margin=0.80, logscale=TRUE, CV=0.20, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-062",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A psychiatrist is designing a non-inferiority trial for chronic pain using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 36,
        "power": 0.8203
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_a025_cv25_t095_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.025, targetpower=0.80, margin=0.80, logscale=TRUE, CV=0.25, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-063",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A pediatrician is designing a non-inferiority trial for asthma using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 30,
        "power": 0.9003
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.027
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_a025_cv20_t095_p90",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.025, targetpower=0.90, margin=0.80, logscale=TRUE, CV=0.20, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-064",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A endocrinologist is designing a non-inferiority trial for COPD using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 48,
        "power": 0.8017
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0241
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_a025_cv30_t095_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.025, targetpower=0.80, margin=0.80, logscale=TRUE, CV=0.30, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-065",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A orthopedic surgeon is designing a non-inferiority trial for rheumatoid arthritis using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 48,
        "power": 0.8139
      },
      "tolerance": {
        "sample_size": 3,
        "power": 0.0244
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_a025_cv20_t090_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.025, targetpower=0.80, margin=0.80, logscale=TRUE, CV=0.20, theta0=0.90, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-066",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A gastroenterologist is designing a non-inferiority trial for breast cancer using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 18,
        "power": 0.8012
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.024
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_a050_cv20_t095_p80",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.050, targetpower=0.80, margin=0.80, logscale=TRUE, CV=0.20, theta0=0.95, design=\"2x2\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-067",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A pulmonologist is designing a non-inferiority trial for heart failure using the primary endpoint. The non-inferiority margin is 0.8. What is the statistical power?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "sample_size": 68,
        "power": 0.8094
      },
      "tolerance": {
        "sample_size": 4,
        "power": 0.0243
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.noninf",
        "origin": "PowerTOST::sampleN.noninf CRAN docs / direct computation",
        "variation": "noninf_parallel_cv25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.noninf(alpha=0.025, targetpower=0.80, margin=0.80, logscale=TRUE, CV=0.25, theta0=0.95, design=\"parallel\", print=FALSE)",
      "tier": 3
    },
    {
      "id": "t3-ptost-068",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A rheumatologist has 24 participants per group for a non-inferiority trial using the primary endpoint. The non-inferiority margin is 0.8. What power is achieved at significance level of 0.025?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "power": 0.8193
      },
      "tolerance": {
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.noninf",
        "origin": "PowerTOST::power.noninf CRAN docs / direct computation",
        "variation": "pnoninf_n24_cv20",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.noninf(alpha=0.025, n=24, CV=0.20, theta0=0.95, margin=0.80, logscale=TRUE, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-069",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A dermatologist has 30 participants per group for a non-inferiority trial using the primary endpoint. The non-inferiority margin is 0.8. What power is achieved at significance level of 0.025?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "power": 0.742
      },
      "tolerance": {
        "power": 0.0223
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.noninf",
        "origin": "PowerTOST::power.noninf CRAN docs / direct computation",
        "variation": "pnoninf_n30_cv25",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.noninf(alpha=0.025, n=30, CV=0.25, theta0=0.95, margin=0.80, logscale=TRUE, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-070",
      "template": "non_inferiority",
      "difficulty": "intermediate",
      "question": "A ophthalmologist has 40 participants per group for a non-inferiority trial using the primary endpoint. The non-inferiority margin is 0.8. What power is achieved at significance level of 0.025?",
      "expected_template": "non_inferiority",
      "ground_truth": {
        "power": 0.7229
      },
      "tolerance": {
        "power": 0.0217
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.noninf",
        "origin": "PowerTOST::power.noninf CRAN docs / direct computation",
        "variation": "pnoninf_n40_cv30",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.noninf(alpha=0.025, n=40, CV=0.30, theta0=0.95, margin=0.80, logscale=TRUE, design=\"2x2\")",
      "tier": 3
    },
    {
      "id": "t3-ptost-071",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a narrow therapeutic index drug (NTID) bioequivalence study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.05. The expected geometric mean ratio (test/reference) is 0.975. What is the statistical power?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "sample_size": 32,
        "power": 0.8081
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0242
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.NTID",
        "origin": "PowerTOST::sampleN.NTID CRAN docs / direct computation",
        "variation": "ntid_cv05_t0975",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.NTID(alpha=0.05, targetpower=0.80, CV=0.05, theta0=0.975, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-072",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a narrow therapeutic index drug (NTID) bioequivalence study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.1. The expected geometric mean ratio (test/reference) is 0.975. What is the statistical power?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "sample_size": 18,
        "power": 0.8418
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0253
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.NTID",
        "origin": "PowerTOST::sampleN.NTID CRAN docs / direct computation",
        "variation": "ntid_cv10_t0975",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.NTID(alpha=0.05, targetpower=0.80, CV=0.10, theta0=0.975, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-073",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a narrow therapeutic index drug (NTID) bioequivalence study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.15. The expected geometric mean ratio (test/reference) is 0.975. What is the statistical power?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "sample_size": 16,
        "power": 0.8415
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0252
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.NTID",
        "origin": "PowerTOST::sampleN.NTID CRAN docs / direct computation",
        "variation": "ntid_cv15_t0975",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.NTID(alpha=0.05, targetpower=0.80, CV=0.15, theta0=0.975, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-074",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a narrow therapeutic index drug (NTID) bioequivalence study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.1. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "sample_size": 34,
        "power": 0.8184
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0246
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.NTID",
        "origin": "PowerTOST::sampleN.NTID CRAN docs / direct computation",
        "variation": "ntid_cv10_t0950",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.NTID(alpha=0.05, targetpower=0.80, CV=0.10, theta0=0.950, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-075",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a narrow therapeutic index drug (NTID) bioequivalence study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.1. The expected geometric mean ratio (test/reference) is 1.0. What is the statistical power?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "sample_size": 14,
        "power": 0.8158
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0245
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.NTID",
        "origin": "PowerTOST::sampleN.NTID CRAN docs / direct computation",
        "variation": "ntid_cv10_t1000",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.NTID(alpha=0.05, targetpower=0.80, CV=0.10, theta0=1.000, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-076",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A narrow therapeutic index drug (NTID) bioequivalence study uses a 2x2x4 crossover design with 18 participants per group. The within-subject coefficient of variation (CV) is 0.1. The expected geometric mean ratio (test/reference) is 0.975. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "power": 0.8418
      },
      "tolerance": {
        "power": 0.0253
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.NTID",
        "origin": "PowerTOST::power.NTID CRAN docs / direct computation",
        "variation": "pntid_n18_cv10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.NTID(alpha=0.05, n=18, CV=0.10, theta0=0.975, design=\"2x2x4\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-077",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A narrow therapeutic index drug (NTID) bioequivalence study uses a 2x2x4 crossover design with 24 participants per group. The within-subject coefficient of variation (CV) is 0.1. The expected geometric mean ratio (test/reference) is 0.975. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "power": 0.9323
      },
      "tolerance": {
        "power": 0.028
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.NTID",
        "origin": "PowerTOST::power.NTID CRAN docs / direct computation",
        "variation": "pntid_n24_cv10",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.NTID(alpha=0.05, n=24, CV=0.10, theta0=0.975, design=\"2x2x4\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-078",
      "template": "bioequivalence_ntid",
      "difficulty": "advanced",
      "question": "A narrow therapeutic index drug (NTID) bioequivalence study uses a 2x2x4 crossover design with 16 participants per group. The within-subject coefficient of variation (CV) is 0.05. The expected geometric mean ratio (test/reference) is 0.975. What power is achieved at significance level of 0.05?",
      "expected_template": "bioequivalence_ntid",
      "ground_truth": {
        "power": 0.5286
      },
      "tolerance": {
        "power": 0.0159
      },
      "source": {
        "package": "PowerTOST",
        "function": "power.NTID",
        "origin": "PowerTOST::power.NTID CRAN docs / direct computation",
        "variation": "pntid_n16_cv05",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\npower.NTID(alpha=0.05, n=16, CV=0.05, theta0=0.975, design=\"2x2x4\", nsims=1e5)",
      "tier": 3
    },
    {
      "id": "t3-ptost-079",
      "template": "bioequivalence_hvntid",
      "difficulty": "advanced",
      "question": "A pharmaceutical company is planning a narrow therapeutic index drug (NTID) bioequivalence study using a 2x2x4 crossover design. The within-subject coefficient of variation (CV) is 0.3. The expected geometric mean ratio (test/reference) is 0.95. What is the statistical power?",
      "expected_template": "bioequivalence_hvntid",
      "ground_truth": {
        "sample_size": 22,
        "power": 0.8297
      },
      "tolerance": {
        "sample_size": 2,
        "power": 0.0249
      },
      "source": {
        "package": "PowerTOST",
        "function": "sampleN.HVNTID",
        "origin": "PowerTOST::sampleN.HVNTID CRAN docs / direct computation",
        "variation": "hvntid_cv30_t095",
        "supplement": true,
        "source_type": "claude_generated"
      },
      "reference_code": "library(PowerTOST)\nsampleN.HVNTID(alpha=0.05, targetpower=0.80, CV=0.30, theta0=0.95, design=\"2x2x4\", print=FALSE, nsims=1e5)",
      "tier": 3
    }
  ]
}